syndrome	score	normalized_score
DRAVET SYNDROME	2.6698290399999998	100.0
CHILDHOOD ABSENCE EPILEPSY	1.52620533	57.164908581562216
MYOCLONIC-ASTASTIC EPILEPSY	1.223545494	45.828608336659634
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.71050326128747
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1564266	43.31463111211047
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	1.077468654	40.35721530693966
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	1.0350242189999999	38.76743429983816
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.45558180009908
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.45558180009908
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.00002232352675
LAFORA DISEASE	0.77152896	28.898066072425376
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.863911825605136
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7485789639999998	28.038460619935417
EARLY MYOCLONIC ENCEPHALOPATHY	0.708728914	26.545853812422394
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.680345954	25.482753532413447
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59705175	22.36292066101731
ROLANDIC EPILEPSY	0.59608578	22.326739692665868
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.808658220303126
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5552363	20.79669865303436
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	19.976297808192246
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.74010290936082
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.516847064	19.358807483793047
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	18.99156247098129
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.500545554	18.748224942522913
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.72779090004954
BRANCHIOOTORENAL SYNDROME 1	0.5	18.72779090004954
CREST SYNDROME	0.5	18.72779090004954
INHALATIONAL ANTHRAX	0.5	18.72779090004954
PAROXYSMAL HEMICRANIA	0.5	18.72779090004954
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.72779090004954
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.43744392	16.384716528515998
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42505119	15.920539616274459
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.415131304	15.5489845147538
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.315261534498855
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.40130846	15.03124185060179
SPINOCEREBELLAR ATAXIA TYPE 42	0.3888886	14.566048768426013
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.65480353004176
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.39103195911001
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.39103195911001
CENTRALOPATHIC EPILEPSY	0.3547009	13.285528574518764
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.349683194	13.097587476986916
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.34857384399999997	13.056036127316975
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	12.915707142057306
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34259226	12.831992418510813
ACITRETIN/ETRETINATE EMBRYOPATHY	0.34173636	12.799934186048109
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.748953019104176
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.33933889899999997	12.710135889450061
COG4-CDG	0.333878554	12.5056154906458
EPIDERMAL NEVUS SYNDROME	0.333878554	12.5056154906458
NEUROMYELITIS OPTICA	0.333333	12.485181448172428
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.485181448172428
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.485181448172428
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.485181448172428
PLACENTAL INSUFFICIENCY	0.333333	12.485181448172428
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.32818681000000005	12.292427907668579
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.284670646926516
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.2743156	10.27465039484326
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.259940294	9.736214945058807
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.254851759	9.545620906123638
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.254851759	9.545620906123638
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.254851759	9.545620906123638
GM2 GANGLIOSIDOSIS, AB VARIANT	0.254851759	9.545620906123638
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.251086973	9.40460865614077
PALLISTER-HALL SYNDROME	0.250545554	9.384329492498141
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.250545554	9.384329492498141
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.250545554	9.384329492498141
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.36389545002477
HYPEREKPLEXIA 1; HKPX1	0.25	9.36389545002477
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.25	9.36389545002477
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.24444441	9.155807594331959
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24304515400000004	9.10339764676468
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.234614804	8.787633982736214
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.711093726061202
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.462307758851857
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.22510605000000003	8.431478069472195
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.216847064	8.122132943763322
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.20518830000000002	7.6854471550732715
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.2	7.491116360019817
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	7.491116360019817
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.491116360019817
BENIGN SCHWANNOMA	0.2	7.491116360019817
POLYARTERITIS NODOSA	0.2	7.491116360019817
MALARIA	0.2	7.491116360019817
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.491116360019817
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.19106063399999998	7.156287205565791
MYOCLONIC EPILEPSY OF INFANCY	0.19106063399999998	7.156287205565791
JUVENILE MYOCLONIC EPILEPSY	0.1829753	6.853446316547671
UNILATERAL POLYMICROGYRIA	0.17540910999999998	6.570050268087578
MUCOLIPIDOSIS TYPE II	0.17407441	6.520058303058987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.172753954	6.470599855337554
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.17206431300000002	6.444768950449353
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17042955399999998	6.3835381010014025
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.168466454	6.310009048369629
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.167208419	6.262888615519742
CEREBROOCULONASAL SYNDROME	0.166667	6.242609451877114
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	6.242609451877114
DERMATOLEUKODYSTROPHY	0.166667	6.242609451877114
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.15950570000000003	5.974378793932066
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.15950570000000003	5.974378793932066
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.15457474999999998	5.789687192854865
TUBEROUS SCLEROSIS COMPLEX	0.15391778	5.765079999279655
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.718037062028511
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15266181399999998	5.718037062028511
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.15260886	5.7160536391498695
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.67794782844972
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.15077670999999998	5.647429394954817
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.14880960000000001	5.573750145440025
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.143402554	5.371226091690126
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.350792049216754
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.350792049216754
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.13870195000000002	5.1951622340582535
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13678895400000002	5.123509855896991
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.962066784620787
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12522615399999998	4.690418454658804
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11869880399999999	4.445932762795928
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.425498720322556
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.11796315000000002	4.418378414222359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.111069204	4.1601616558938925
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.10714290000000001	4.013099655249837
SCHINZEL-GIEDION SYNDROME	0.10714290000000001	4.013099655249837
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.106797214	4.000151784999687
BILATERAL POLYMICROGYRIA	0.104660764	3.9201298072628656
AICARDI SYNDROME; AIC	0.1036867	3.8836456734323335
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0992976	3.719249379353519
GITELMAN SYNDROME	0.09903390000000001	3.7093723424328333
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.7063460812457123
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.098393854	3.6853990471240063
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.098393854	3.6853990471240063
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185000000001	3.675210979052053
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185000000001	3.675210979052053
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185000000001	3.675210979052053
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185000000001	3.675210979052053
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185000000001	3.675210979052053
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0941662	3.5270498069044907
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.093138154	3.4885437458572257
ADNP SYNDROME	0.09164844899999999	3.4327459783717087
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.09143154	3.4246215255790315
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08645022000000001	3.238043286846562
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.08618236000000001	3.2280104347055882
SPINOCEREBELLAR ATAXIA TYPE 36	0.08540178000000001	3.1987733566640664
CONGENITAL ENTEROVIRUS INFECTION	0.08532646	3.1959522022428826
BECKWITH-WIEDEMANN SYNDROME	0.08532646	3.1959522022428826
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.083878954	3.1417350228537484
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.081774859	3.062924920466069
ETHYLMALONIC ENCEPHALOPATHY	0.081774859	3.062924920466069
AICARDI SYNDROME	0.08133220999999999	3.0463452446378363
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.08123344	3.042645756823441
SPINAL MUSCULAR ATROPHY, TYPE II	0.0799373	2.9940980790290608
SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	0.0799373	2.9940980790290608
SPINAL MUSCULAR ATROPHY, TYPE IV	0.0799373	2.9940980790290608
SALT-AND-PEPPER SYNDROME	0.07894804400000001	2.9570449199998223
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.901633506840574
DDOST-CDG	0.07746451900000001	2.90147862800983
TRISOMY 8P	0.07746451900000001	2.90147862800983
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.07746451900000001	2.90147862800983
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.881199464367202
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07692310000000001	2.881199464367202
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.881199464367202
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	2.881199464367202
TRICHOHEPATOENTERIC SYNDROME 1	0.07692310000000001	2.881199464367202
AMISH INFANTILE EPILEPSY SYNDROME	0.07641829	2.8622915121186936
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07628449400000001	2.857280105096168
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.07533176	2.821594898825432
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07392479999999998	2.768896393455964
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.07300403999999999	2.7344087919577054
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07289361	2.7302725720595205
9P13 MICRODELETION SYNDROME	0.07220537999999999	2.704494516997238
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.695833812639929
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.06726344399999999	2.5193914288983836
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067212254	2.5174740776660367
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.517319198835293
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.4970400351926654
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0666667	2.4970400351926654
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.4970400351926654
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.4970400351926654
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.4970400351926654
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.4970400351926654
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.4970400351926654
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.4970400351926654
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.4970400351926654
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.4970400351926654
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.4970400351926654
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.4970400351926654
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.4970400351926654
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.065901773	2.468389249373061
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4276760432570623
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.064030564	2.3983020276084797
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.06296301	2.358316171435457
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.0627413	2.350011894394557
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.344638891185333
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.060952913000000004	2.2830268188258227
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.060411494	2.2627476551831953
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.060411494	2.2627476551831953
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.060411494	2.2627476551831953
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.060277359999999995	2.25772358817402
49,XYYYY SYNDROME	0.059523799999999995	2.2294985599527375
49,XXXYY SYNDROME	0.059523799999999995	2.2294985599527375
DISTAL MONOSOMY 10Q	0.058433113	2.188646243805933
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.057777909999999995	2.1641052342437628
RFT1-CDG	0.056642573	2.1215805263695837
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.056642573	2.1215805263695837
WHITE-SUTTON SYNDROME; WHSUS	0.056101154	2.101301362726956
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.056097019000000005	2.1011464838962124
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.056097019000000005	2.1011464838962124
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.080867320253585
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	2.080867320253585
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.055555600000000004	2.080867320253585
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.080867320253585
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.080867320253585
MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT	0.055555600000000004	2.080867320253585
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.055555600000000004	2.080867320253585
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.080867320253585
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.080867320253585
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.080867320253585
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.080867320253585
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.080867320253585
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.080867320253585
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.055555600000000004	2.080867320253585
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.080867320253585
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.055555600000000004	2.080867320253585
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.080867320253585
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.055555600000000004	2.080867320253585
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.080867320253585
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.080867320253585
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.05471376	2.049335713270989
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.05453858999999999	2.0427746190070657
PANDAS	0.05325312	1.9946265922704924
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.05249174	1.966108661399533
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.051281214	1.9207677057853862
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9170185893251055
XQ12-Q13.3 DUPLICATION SYNDROME	0.05092595999999999	1.9074614605285736
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.050851813	1.904684241504842
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.050310394	1.8844050778622143
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.050306259000000006	1.884250199031471
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.050029753	1.8738935059302526
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.8382021194885196
WILLIAMS-BEUREN SYNDROME; WBS	0.048942780000000005	1.8331802998142535
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.048875613000000005	1.8306645207514862
CHRISTIANSON SYNDROME	0.04875475	1.8261375267683808
XP22.13P22.2 DUPLICATION SYNDROME	0.047672598999999996	1.7856049314678217
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.04670776	1.7494663253793958
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.046541473	1.7432379490486027
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.046541473	1.7432379490486027
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.046000054	1.7229587854059751
HAMAMY SYNDROME; HMMS	0.04597704	1.7220967826464275
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.045956699999999996	1.7213349361126136
NON-DISTAL MONOSOMY 20Q	0.045671408999999996	1.7106491957252814
SPASTIC PARAPLEGIA-PAGET DISEASE OF BONE SYNDROME	0.0454545	1.702524742932604
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.0454545	1.702524742932604
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.0454545	1.702524742932604
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.0454545	1.702524742932604
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0454545	1.702524742932604
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.0454545	1.702524742932604
MICROHYDRANENCEPHALY; MHAC	0.04497356	1.6845108554216641
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.682711114716169
ZELLWEGER SYNDROME	0.044659079000000004	1.6727317866015872
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.044565273	1.669218228295247
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.044565273	1.669218228295247
MENTAL RETARDATION, X-LINKED 90	0.044565273	1.669218228295247
CITRULLINEMIA TYPE II	0.044565273	1.669218228295247
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.044444410000000004	1.664691234312142
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297954	1.6592056396240265
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.044023854	1.6489390646526194
GITELMAN SYNDROME	0.044019719000000006	1.648784185821876
7Q11.23 MICRODUPLICATION SYNDROME	0.044019719000000006	1.648784185821876
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.043663129	1.6354278999077785
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.043663129	1.6354278999077785
LISSENCEPHALY, X-LINKED, 2	0.043663129	1.6354278999077785
HINMAN SYNDROME	0.043478300000000004	1.6285050221792483
ENAMEL-RENAL SYNDROME	0.043478300000000004	1.6285050221792483
POSTERIOR MENINGOCELE	0.043478300000000004	1.6285050221792483
SENIOR-LOKEN SYNDROME 3	0.043478300000000004	1.6285050221792483
UROFACIAL SYNDROME	0.043478300000000004	1.6285050221792483
UROFACIAL SYNDROME 2	0.043478300000000004	1.6285050221792483
PRIMARY HYPEROXALURIA TYPE 1	0.043478300000000004	1.6285050221792483
204690 ENAMEL-RENAL SYNDROME; ERS;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC, AND NEPHROCALCINOSIS;;AMELOGENESIS IMPERFECTA, TYPE IG; AI1G	0.043478300000000004	1.6285050221792483
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.043266764	1.6205818182275824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.043248754	1.6199072431993624
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04312171000000001	1.6151487362651509
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.6014714560150265
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.042756550000000004	1.6014714560150265
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.6014714560150265
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0427032	1.5994732007259909
DISTAL MONOSOMY 12Q	0.04221225399999999	1.5810845326635594
COG2-CDG	0.04221225399999999	1.5810845326635594
PGM3-CDG	0.042208118999999995	1.5809296538328161
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.042208118999999995	1.5809296538328161
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.042208118999999995	1.5809296538328161
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.042208118999999995	1.5809296538328161
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042208118999999995	1.5809296538328161
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.042021954	1.5739567354470008
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.041724334	1.5628092051916553
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.041676283999999994	1.5610094644861605
DISTAL 17P13.1 MICRODELETION SYNDROME	0.041666699999999994	1.5606504901901883
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.041666699999999994	1.5606504901901883
HISTIDINEMIA	0.041666699999999994	1.5606504901901883
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	1.5606504901901883
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	1.5606504901901883
CANAVAN DISEASE	0.04134734	1.548688675586509
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.04134734	1.548688675586509
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.041271154	1.5458350846314866
CONGENITAL ANALBUMINEMIA	0.040661459999999996	1.5229986411414569
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.040566059	1.5194253411821457
ALPERS-HUTTENLOCHER SYNDROME	0.039675944000000005	1.4860855659881507
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.03930035	1.4720174741975238
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4709593540116714
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.038925143999999995	1.4579639151726358
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4428377031961566
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.03837959	1.4375298726992647
TUBEROUS SCLEROSIS 2; TSC2	0.038263999	1.4332003445434096
TUBEROUS SCLEROSIS-1	0.038263999	1.4332003445434096
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4189395437844214
LISSENCEPHALY 2; LIS2	0.037582554	1.407676425603641
16P13.11 MICRODELETION SYNDROME	0.037582554	1.407676425603641
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.037582554	1.407676425603641
TRICHOTHIODYSTROPHY	0.037582554	1.407676425603641
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3872423831302698
MCLEOD SYNDROME; MCLDS	0.037037	1.3872423831302698
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3872423831302698
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3872423831302698
MYOCLONUS AND ATAXIA	0.037037	1.3872423831302698
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037037	1.3872423831302698
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.036801273	1.3784130911992778
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.036801273	1.3784130911992778
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036801273	1.3784130911992778
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.036801273	1.3784130911992778
MENTAL RETARDATION, X-LINKED 98; MRX98	0.036765933	1.3770894109384624
3P25.3 MICRODELETION SYNDROME	0.03669139	1.3742973595043375
WEST SYNDROME	0.03656844	1.3696921957220154
YOU-HOOVER-FONG SYNDROME; YHFS	0.036259854	1.35813392755665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.036255719000000006	1.3579790487259067
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.036255719000000006	1.3579790487259067
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.036255719000000006	1.3579790487259067
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.036255719000000006	1.3579790487259067
SLC39A8-CDG	0.036255719000000006	1.3579790487259067
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.036255719000000006	1.3579790487259067
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.036255719000000006	1.3579790487259067
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.036255719000000006	1.3579790487259067
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.035714300000000004	1.3376998850832789
JUVENILE ABSENCE EPILEPSY	0.03566625	1.3359001443777838
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3359001443777838
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3359001443777838
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.035569773	1.3322865422124557
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.035028354	1.3120073785698279
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.035028354	1.3120073785698279
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.035028354	1.3120073785698279
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.035028354	1.3120073785698279
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.035028354	1.3120073785698279
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.035024219	1.3118524997390846
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.035024219	1.3118524997390846
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3042052310585404
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3042052310585404
DOORS SYNDROME	0.034614804	1.296517622716397
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.0344828	1.2915733360964567
TREMOR, HEREDITARY ESSENTIAL, 1	0.0344828	1.2915733360964567
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.0344828	1.2915733360964567
SPINOCEREBELLAR ATAXIA TYPE 27	0.0344828	1.2915733360964567
NORMAL PRESSURE HYDROCEPHALUS	0.0344828	1.2915733360964567
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.0344828	1.2915733360964567
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.0344828	1.2915733360964567
X-LINKED DYSTONIA-PARKINSONISM	0.0344828	1.2915733360964567
PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK	0.0344828	1.2915733360964567
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.0344828	1.2915733360964567
DYSTONIA 7, TORSION	0.0344828	1.2915733360964567
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.0344828	1.2915733360964567
CRANIO-CERVICAL DYSTONIA WITH LARYNGEAL AND UPPER-LIMB INVOLVEMENT	0.0344828	1.2915733360964567
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.03443441	1.2897608604931499
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2760835802430255
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.033787834	1.2655429802351692
CHROMOSOME 1P36 DELETION SYNDROME	0.033345072999999996	1.2489591093817751
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.033328053999999996	1.2483216528351193
PEHO SYNDROME	0.032803653999999995	1.2286799457391473
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.032803653999999995	1.2286799457391473
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	1.2286799457391473
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.032803653999999995	1.2286799457391473
SLC35A2-CDG	0.032803653999999995	1.2286799457391473
DEND SYNDROME	0.032799519	1.228525066908404
OCULODENTODIGITAL DYSPLASIA	0.032799519	1.228525066908404
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.032799519	1.228525066908404
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.228525066908404
SECKEL SYNDROME	0.0322581	1.2082459032657762
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.0322581	1.2082459032657762
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	1.2082459032657762
ALG13-CDG	0.0322581	1.2082459032657762
MEIER-GORLIN SYNDROME 5; MGORS5	0.0322581	1.2082459032657762
ISOTRETINOIN-LIKE SYNDROME	0.0322581	1.2082459032657762
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.0322581	1.2082459032657762
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0322581	1.2082459032657762
DYSTONIA, JUVENILE-ONSET	0.0322581	1.2082459032657762
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	1.2082459032657762
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0322581	1.2082459032657762
SECKEL SYNDROME 2; SCKL2	0.0322581	1.2082459032657762
MILD CANAVAN DISEASE	0.0322581	1.2082459032657762
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	1.2082459032657762
DENT DISEASE	0.0322581	1.2082459032657762
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0322581	1.2082459032657762
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	1.2082459032657762
COG1-CDG	0.0322581	1.2082459032657762
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0322581	1.2082459032657762
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	1.2082459032657762
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2082459032657762
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.03208814	1.2018799525830315
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.169622081869332
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.1128417795620353
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0721285734460362
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0721285734460362
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341364	1.0615422776283834
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.028341364	1.0615422776283834
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.027977684	1.0479204316393234
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0404336601267925
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0404336601267925
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.027777800000000002	1.0404336601267925
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.027777800000000002	1.0404336601267925
MENINGIOMA	0.027777800000000002	1.0404336601267925
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0404336601267925
GANGLIOCYTOMA	0.027777800000000002	1.0404336601267925
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0327460517846492
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.0325911729539057
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0123120093112778
CHROMOSOME 17Q12 DELETION SYNDROME	0.027027	1.0123120093112778
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0123120093112778
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0123120093112778
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0123120093112778
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.025805929000000002	0.9665760845870492
LISSENCEPHALY 5; LIS5	0.025805929000000002	0.9665760845870492
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.025805929000000002	0.9665760845870492
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.025609453999999997	0.9592169991528745
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.02489935	0.932619640694297
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730214	0.9262845534109556
ADRENOLEUKODYSTROPHY	0.023862999000000003	0.8938025110401827
PRADER-WILLI SYNDROME	0.023862999000000003	0.8938025110401827
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.023392444	0.8761775997462369
SPASTIC PARAPLEGIA TYPE 7	0.02332158	0.8735233473975548
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.023212049999999998	0.8694208375229899
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.022708859	0.8505735258614163
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8432451540043179
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8432451540043179
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8432451540043179
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8228111115309467
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.021814674	0.8170813064494946
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.021647428999999996	0.810817047671337
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7972946462519562
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.020935434	0.7841488607075755
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.776860603778585
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.776860603778585
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.776860603778585
GAUCHER DISEASE	0.02061185	0.7720288337263723
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.020443214	0.7657124742339309
NIEMANN-PICK DISEASE TYPE B	0.02038988	0.7637148182342043
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.019781293999999998	0.7409198755288091
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.01916308	0.7177643104818427
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.01916308	0.7177643104818427
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.7147313072899979
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.018944073000000002	0.7095612758785486
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.018944073000000002	0.7095612758785486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.018944073000000002	0.7095612758785486
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.018944073000000002	0.7095612758785486
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.018944073000000002	0.7095612758785486
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.018944073000000002	0.7095612758785486
LISSENCEPHALY 1; LIS1	0.018944073000000002	0.7095612758785486
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6942972648166267
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.01853655	0.6942972648166267
GABRIELE-DE VRIES SYNDROME; GADEVS	0.018402654	0.6892821122359206
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.018402654	0.6892821122359206
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.018402654	0.6892821122359206
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.018402654	0.6892821122359206
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.018402654	0.6892821122359206
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.018402654	0.6892821122359206
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.018402654	0.6892821122359206
PEROXISOME BIOGENESIS DISORDER 6B	0.018402654	0.6892821122359206
RIDDLE SYNDROME	0.018402654	0.6892821122359206
MERCURY POISONING	0.018398519000000002	0.6891272334051772
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.018398519000000002	0.6891272334051772
CHROMOSOME 18Q DELETION SYNDROME	0.018398519000000002	0.6891272334051772
JUVENILE HUNTINGTON DISEASE	0.018398519000000002	0.6891272334051772
MEGALENCEPHALY WITH DYSMYELINATION	0.018398519000000002	0.6891272334051772
OCULODENTODIGITAL DYSPLASIA; ODDD	0.018398519000000002	0.6891272334051772
METACHROMATIC LEUKODYSTROPHY	0.018398519000000002	0.6891272334051772
NEPHROPATHIC INFANTILE CYSTINOSIS	0.0178571	0.6688480697625494
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.0178571	0.6688480697625494
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.0178571	0.6688480697625494
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0178571	0.6688480697625494
ATAXIA-PANCYTOPENIA SYNDROME	0.0178571	0.6688480697625494
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.0178571	0.6688480697625494
PROGRESSIVE NON-FLUENT APHASIA	0.0178571	0.6688480697625494
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.0178571	0.6688480697625494
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0178571	0.6688480697625494
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.0178571	0.6688480697625494
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.0178571	0.6688480697625494
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.0178571	0.6688480697625494
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.0178571	0.6688480697625494
NEONATAL LUPUS ERYTHEMATOSUS	0.0178571	0.6688480697625494
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0178571	0.6688480697625494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.017504334	0.6556350139932556
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.017504334	0.6556350139932556
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6457866680482284
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6457866680482284
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6457866680482284
MYOPATHY, CONGENITAL	0.0172414	0.6457866680482284
DIASTEMATOMYELIA	0.0172414	0.6457866680482284
SICKLE CELL ANEMIA	0.0172414	0.6457866680482284
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6457866680482284
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6457866680482284
CARDIAC ARRHYTHMIA	0.0172414	0.6457866680482284
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6457866680482284
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6457866680482284
CERVICAL RIB	0.0172414	0.6457866680482284
TRANSSEXUALITY	0.0172414	0.6457866680482284
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6457866680482284
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6457866680482284
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6457866680482284
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6457866680482284
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6457866680482284
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6457866680482284
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6457866680482284
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6457866680482284
THUMBS, CONGENITAL CLASPED	0.0172414	0.6457866680482284
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6457866680482284
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6457866680482284
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6457866680482284
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6457866680482284
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6457866680482284
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6457866680482284
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6457866680482284
ALCOHOL DEPENDENCE	0.0172414	0.6457866680482284
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6457866680482284
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6457866680482284
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6457866680482284
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6457866680482284
ERYTHERMALGIA, PRIMARY	0.0172414	0.6457866680482284
MOSAIC TRISOMY 15	0.0172414	0.6457866680482284
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6457866680482284
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6457866680482284
269800 SENILE PLAQUE FORMATION	0.0172414	0.6457866680482284
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6457866680482284
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6457866680482284
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6457866680482284
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6457866680482284
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6457866680482284
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6457866680482284
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6457866680482284
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6457866680482284
PALMOMENTAL REFLEX	0.0172414	0.6457866680482284
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6457866680482284
MOTION SICKNESS	0.0172414	0.6457866680482284
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6457866680482284
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6457866680482284
RHEUMATOID ARTHRITIS	0.0172414	0.6457866680482284
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6457866680482284
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.016897743	0.6329147951735516
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.016891613	0.6326851924571171
TRANSIENT NEONATAL DIABETES MELLITUS	0.016847064000000002	0.6310165837435046
PERMANENT NEONATAL DIABETES MELLITUS	0.016847064000000002	0.6310165837435046
MELAS	0.01681707	0.6298931410229923
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.016350194	0.6124060288144892
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.016350194	0.6124060288144892
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.016350194	0.6124060288144892
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.016350194	0.6124060288144892
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.016301509999999998	0.6105825412701331
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6105825412701331
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6105825412701331
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6105825412701331
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6105825412701331
YUNIS-VARON SYNDROME	0.015810770000000002	0.5922015890575527
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.01580464	0.5919719863411179
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.01580464	0.5919719863411179
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.01580464	0.5919719863411179
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.57947358307257
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.015470953999999999	0.57947358307257
HAREL-YOON SYNDROME; HAYOS	0.015470953999999999	0.57947358307257
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.57947358307257
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.57947358307257
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.014954813	0.5601412216266852
FG SYNDROME TYPE 1	0.014954813	0.5601412216266852
JACOBSEN SYNDROME	0.014954813	0.5601412216266852
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5590395405991988
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5590395405991988
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5590395405991988
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5590395405991988
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.014656573	0.5489704689106236
AMISH LETHAL MICROCEPHALY	0.01444966	0.5412204221136198
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01444966	0.5412204221136198
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.01444966	0.5412204221136198
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01444966	0.5412204221136198
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.01444966	0.5412204221136198
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.01444966	0.5412204221136198
CORNELIA DE LANGE SYNDROME	0.014409259	0.5397071791533139
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.014244153999999998	0.5335230753202085
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.014244153999999998	0.5335230753202085
19P13.3 MICRODUPLICATION SYNDROME	0.014244153999999998	0.5335230753202085
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.5335230753202085
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.014244153999999998	0.5335230753202085
AYMÃ‰-GRIPP SYNDROME	0.014244153999999998	0.5335230753202085
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.014244153999999998	0.5335230753202085
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.014244153999999998	0.5335230753202085
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014244153999999998	0.5335230753202085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.5335230753202085
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.014244153999999998	0.5335230753202085
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.013958862999999998	0.5228373349328764
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5130890328468373
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5130890328468373
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.5130890328468373
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5130890328468373
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5130890328468373
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5130890328468373
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.5130890328468373
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5130890328468373
CARNOSINASE DEFICIENCY	0.013569600000000001	0.5082572627946246
8P INVERTED DUPLICATION/DELETION SYNDROME	0.013413308999999998	0.5024032924595052
PELIZAEUS-MERZBACHER DISEASE	0.013255119000000001	0.4964781939745476
GABRIELE-DE VRIES SYNDROME	0.01287189	0.4821241288168774
HYPERPROLINEMIA, TYPE I	0.012581272999999999	0.4712389000008779
COG8-CDG	0.012259168999999999	0.4591743072807388
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.012259168999999999	0.4591743072807388
NEONATAL ADRENOLEUKODYSTROPHY	0.012259168999999999	0.4591743072807388
WRINKLY SKIN SYNDROME	0.012039854	0.45095973635825015
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.45095973635825015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012039854	0.45095973635825015
PEHO-LIKE SYNDROME; PEHOL	0.012039854	0.45095973635825015
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.012039854	0.45095973635825015
PERLMAN SYNDROME	0.012039854	0.45095973635825015
FUMARASE DEFICIENCY; FMRD	0.012039854	0.45095973635825015
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012039854	0.45095973635825015
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.012039854	0.45095973635825015
RING CHROMOSOME 14 SYNDROME	0.012039854	0.45095973635825015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.45095973635825015
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.012039854	0.45095973635825015
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.012039854	0.45095973635825015
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.45095973635825015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.012039854	0.45095973635825015
PYRIDOXINE-DEPENDENT EPILEPSY	0.012039854	0.45095973635825015
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.012039854	0.45095973635825015
BETA-UREIDOPROPIONASE DEFICIENCY	0.012039854	0.45095973635825015
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.45095973635825015
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.012039854	0.45095973635825015
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.45095973635825015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.45095973635825015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.4305256938848789
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.4305256938848789
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.4305256938848789
DESMOSTEROLOSIS	0.011494299999999999	0.4305256938848789
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4305256938848789
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4305256938848789
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.4305256938848789
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.4305256938848789
WITTEVEEN-KOLK SYNDROME	0.010861793000000002	0.40683477620724373
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.010861793	0.4068347762072436
FAMILIAL COLORECTAL CANCER TYPE X	0.010316239000000001	0.3864007337338724
LYNCH SYNDROME	0.010316239000000001	0.3864007337338724
CHOREOACANTHOCYTOSIS	0.010316239000000001	0.3864007337338724
NORRIE DISEASE	0.010316239000000001	0.3864007337338724
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.3672450128117567
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.3672450128117567
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.009804814	0.3672450128117567
BIOTINIDASE DEFICIENCY	0.009804814	0.3672450128117567
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.3672450128117567
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.3672450128117567
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.3672450128117567
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.009804814	0.3672450128117567
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.3672450128117567
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.3672450128117567
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.3672450128117567
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.3672450128117567
KRABBE DISEASE	0.009804814	0.3672450128117567
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.009804814	0.3672450128117567
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.3672450128117567
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.36709013398101326
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.36709013398101326
WILLIAMS SYNDROME	0.00977482	0.3661215700912446
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	0.35546594399167974
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.009490333	0.35546594399167974
GALLOWAY-MOWAT SYNDROME	0.009490333	0.35546594399167974
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009490333	0.35546594399167974
CONGENITAL TOXOPLASMOSIS	0.009490333	0.35546594399167974
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.009490333	0.35546594399167974
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.009490333	0.35546594399167974
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.009490333	0.35546594399167974
EMANUEL SYNDROME	0.009490333	0.35546594399167974
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.009490333	0.35546594399167974
INFANTILE SIALIC ACID STORAGE DISEASE	0.009490333	0.35546594399167974
KAGAMI-OGATA SYNDROME	0.009490333	0.35546594399167974
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.009490333	0.35546594399167974
KAGAMI-OGATA SYNDROME	0.009490333	0.35546594399167974
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.009490333	0.35546594399167974
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.3468109703383854
MERRF	0.00925926	0.3468109703383854
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3468109703383854
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3468109703383854
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3468109703383854
GLYCINE ENCEPHALOPATHY	0.00925926	0.3468109703383854
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3468109703383854
GAUCHER DISEASE TYPE 3	0.00925926	0.3468109703383854
GAUCHER DISEASE TYPE 2	0.00925926	0.3468109703383854
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.3468109703383854
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.3468109703383854
HYDROXYLYSINURIA	0.00925926	0.3468109703383854
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3468109703383854
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3468109703383854
CARNOSINEMIA	0.00925926	0.3468109703383854
PAINE SYNDROME	0.00925926	0.3468109703383854
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3468109703383854
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.3468109703383854
VASCULAR EHLERS-DANLOS SYNDROME	0.008948914	0.3351867803490519
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.008948914	0.3351867803490519
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.008948914	0.3351867803490519
TYSHCHENKO SYNDROME	0.008948914	0.3351867803490519
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.008948914	0.3351867803490519
CINCA SYNDROME	0.008948914	0.3351867803490519
ROBERTS SYNDROME	0.008948914	0.3351867803490519
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.008948914	0.3351867803490519
CARDIOFACIOCUTANEOUS SYNDROME	0.008948914	0.3351867803490519
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.008948914	0.3351867803490519
ROIFMAN SYNDROME; RFMN	0.008948914	0.3351867803490519
PEDIATRIC-ONSET GRAVES DISEASE	0.008948914	0.3351867803490519
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.008948914	0.3351867803490519
COSTELLO SYNDROME; CSTLO	0.008948914	0.3351867803490519
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.008944779	0.3350319015183085
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.008944779	0.3350319015183085
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.3350319015183085
MICROFORM HOLOPROSENCEPHALY	0.008944779	0.3350319015183085
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.008944779	0.3350319015183085
GAUCHER DISEASE, PERINATAL LETHAL	0.008944779	0.3350319015183085
ADAMS-OLIVER SYNDROME	0.008944779	0.3350319015183085
WEBB-DATTANI SYNDROME; WEDAS	0.008494383	0.31816205729787106
PIERPONT SYNDROME	0.008494383	0.31816205729787106
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.008494383	0.31816205729787106
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.008494383	0.31816205729787106
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.008494383	0.31816205729787106
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.008494383	0.31816205729787106
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.008494383	0.31816205729787106
ADENYLOSUCCINASE DEFICIENCY	0.008494383	0.31816205729787106
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.008494383	0.31816205729787106
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.31475273787568064
KNIEST-LIKE DYSPLASIA, LETHAL	0.00840336	0.31475273787568064
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.31475273787568064
HEC SYNDROME	0.00840336	0.31475273787568064
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.31475273787568064
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.31475273787568064
CLASSICAL EHLERS-DANLOS SYNDROME	0.00840336	0.31475273787568064
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.31475273787568064
FATCO SYNDROME	0.00840336	0.31475273787568064
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.31475273787568064
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.31475273787568064
HYDROLETHALUS	0.00840336	0.31475273787568064
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.31475273787568064
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.31475273787568064
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.31475273787568064
RETINOPATHY OF PREMATURITY	0.00840336	0.31475273787568064
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.31475273787568064
VACTERL/VATER ASSOCIATION	0.00840336	0.31475273787568064
PEMPHIGOID GESTATIONIS	0.00840336	0.31475273787568064
SCHISIS ASSOCIATION	0.00840336	0.31475273787568064
NEMALINE MYOPATHY 10	0.00840336	0.31475273787568064
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.31475273787568064
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.31475273787568064
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.31475273787568064
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.31475273787568064
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.31475273787568064
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.31475273787568064
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.31475273787568064
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.31475273787568064
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.31475273787568064
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.31475273787568064
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.31475273787568064
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.31475273787568064
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.31475273787568064
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31475273787568064
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.31475273787568064
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.31475273787568064
OMPHALOCELE	0.00840336	0.31475273787568064
DIAMOND-BLACKFAN ANEMIA 1	0.00840336	0.31475273787568064
SILVER-RUSSELL SYNDROME	0.00840336	0.31475273787568064
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	0.31475273787568064
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.31475273787568064
GMS SYNDROME	0.00840336	0.31475273787568064
DISTAL MONOSOMY 17Q	0.00840336	0.31475273787568064
RENAL TUBULAR DYSGENESIS	0.00840336	0.31475273787568064
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.31475273787568064
RESTRICTIVE DERMOPATHY, LETHAL	0.00840336	0.31475273787568064
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.31475273787568064
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.31475273787568064
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.31475273787568064
EBSTEIN MALFORMATION	0.00840336	0.31475273787568064
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00840336	0.31475273787568064
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00840336	0.31475273787568064
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.31475273787568064
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00840336	0.31475273787568064
TEMPLE SYNDROME	0.00840336	0.31475273787568064
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.31475273787568064
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.31475273787568064
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.31475273787568064
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31475273787568064
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.31475273787568064
TEMPLE SYNDROME	0.00840336	0.31475273787568064
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.29788289365524323
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.29788289365524323
300270 ADRENOMYODYSTROPHY	0.007952964	0.29788289365524323
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.007948829	0.29772801482449973
INTELLECTUAL DISABILITY, WOLFF TYPE	0.007948829	0.29772801482449973
GLUTAMINE DEFICIENCY, CONGENITAL	0.007948829	0.29772801482449973
KEPPEN-LUBINSKY SYNDROME	0.007948829	0.29772801482449973
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.007948829	0.29772801482449973
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.007948829	0.29772801482449973
COFFIN-LOWRY SYNDROME	0.007948829	0.29772801482449973
FRYNS SYNDROME	0.007948829	0.29772801482449973
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.007948829	0.29772801482449973
QAZI-MARKOUIZOS SYNDROME	0.007948829	0.29772801482449973
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007948829	0.29772801482449973
HALL-RIGGS SYNDROME	0.007948829	0.29772801482449973
HENNEKAM-BEEMER SYNDROME	0.007948829	0.29772801482449973
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.007948829	0.29772801482449973
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.007948829	0.29772801482449973
CONO-SPONDYLAR DYSPLASIA	0.007948829	0.29772801482449973
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.007948829	0.29772801482449973
TEMPLE-BARAITSER SYNDROME	0.007948829	0.29772801482449973
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.007948829	0.29772801482449973
2Q24 MICRODELETION SYNDROME	0.007948829	0.29772801482449973
ADRENOMYODYSTROPHY	0.007948829	0.29772801482449973
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.007948829	0.29772801482449973
COFS SYNDROME	0.007948829	0.29772801482449973
MEHMO SYNDROME	0.007948829	0.29772801482449973
TRISOMY 13	0.007948829	0.29772801482449973
BOWEN-CONRADI SYNDROME	0.007948829	0.29772801482449973
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.007948829	0.29772801482449973
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.007948829	0.29772801482449973
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.007948829	0.29772801482449973
HEREDITARY METHEMOGLOBINEMIA	0.007948829	0.29772801482449973
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.007948829	0.29772801482449973
CROME SYNDROME	0.007948829	0.29772801482449973
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.007948829	0.29772801482449973
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.007948829	0.29772801482449973
21Q22.11Q22.12 MICRODELETION SYNDROME	0.007948829	0.29772801482449973
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.29772801482449973
ADENYLOSUCCINATE LYASE DEFICIENCY	0.007948829	0.29772801482449973
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.007948829	0.29772801482449973
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.007948829	0.29772801482449973
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.007948829	0.29772801482449973
1Q41Q42 MICRODELETION SYNDROME	0.007948829	0.29772801482449973
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.007948829	0.29772801482449973
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.007948829	0.29772801482449973
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.007948829	0.29772801482449973
DPM1-CDG	0.007948829	0.29772801482449973
SMITH-FINEMAN-MYERS SYNDROME	0.007948829	0.29772801482449973
LOWRY-MACLEAN SYNDROME	0.007948829	0.29772801482449973
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.007948829	0.29772801482449973
SECKEL SYNDROME 7; SCKL7	0.007948829	0.29772801482449973
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.007948829	0.29772801482449973
4Q21 MICRODELETION SYNDROME	0.007948829	0.29772801482449973
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.29772801482449973
PITT-HOPKINS-LIKE SYNDROME	0.007948829	0.29772801482449973
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007587804	0.284205613405119
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.284205613405119
OROFACIODIGITAL SYNDROME TYPE 2	0.007587804	0.284205613405119
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.007587804	0.284205613405119
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.284205613405119
PELGER-HUET ANOMALY; PHA	0.007587804	0.284205613405119
1Q44 MICRODELETION SYNDROME	0.007587804	0.284205613405119
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.007587804	0.284205613405119
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.284205613405119
X SMALL RINGS	0.007587804	0.284205613405119
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.284205613405119
W SYNDROME	0.007587804	0.284205613405119
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.284205613405119
SARCOSINEMIA	0.007587804	0.284205613405119
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.284205613405119
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.284205613405119
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.28405073457437563
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28405073457437563
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.2774488511818719
ALLAN-HERNDON-DUDLEY SYNDROME	0.00740741	0.2774488511818719
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00740741	0.2774488511818719
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.2774488511818719
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.00740741	0.2774488511818719
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.2774488511818719
MONOSOMY 5P	0.00740741	0.2774488511818719
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.2774488511818719
RING CHROMOSOME 7 SYNDROME	0.00740741	0.2774488511818719
TRISOMY XQ28	0.00740741	0.2774488511818719
WARBURG MICRO SYNDROME 2; WARBM2	0.00740741	0.2774488511818719
CRANIOFACIAL DYSSYNOSTOSIS	0.00740741	0.2774488511818719
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00740741	0.2774488511818719
DISTAL MONOSOMY 10P	0.00740741	0.2774488511818719
KID SYNDROME	0.00740741	0.2774488511818719
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.2774488511818719
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.2774488511818719
ALLAN-HERNDON-DUDLEY SYNDROME	0.00740741	0.2774488511818719
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.2774488511818719
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00740741	0.2774488511818719
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26377157093174775
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.26377157093174775
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00704225	0.26377157093174775
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26377157093174775
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26377157093174775
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26377157093174775
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26377157093174775
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26377157093174775
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.26377157093174775
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.26377157093174775
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.26377157093174775
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26377157093174775
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26377157093174775
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26377157093174775
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.26377157093174775
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.26377157093174775
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26377157093174775
OLIVER SYNDROME	0.00704225	0.26377157093174775
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.26377157093174775
HALLERMANN-STREIFF SYNDROME; HSS	0.00704225	0.26377157093174775
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26377157093174775
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.0065514530000000005	0.24538848375100455
15Q11Q13 MICRODUPLICATION SYNDROME	0.0065514530000000005	0.24538848375100455
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.0065514530000000005	0.24538848375100455
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.0065514530000000005	0.24538848375100455
22Q11.2 DELETION SYNDROME	0.0065514530000000005	0.24538848375100455
LANDAU-KLEFFNER SYNDROME	0.0065514530000000005	0.24538848375100455
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.0065514530000000005	0.24538848375100455
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.0065514530000000005	0.24538848375100455
SMITH-LEMLI-OPITZ SYNDROME	0.0065514530000000005	0.24538848375100455
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.0065514530000000005	0.24538848375100455
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.0065514530000000005	0.24538848375100455
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.006551453	0.24538848375100453
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.006551453	0.24538848375100453
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.006551453	0.24538848375100453
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.006551453	0.24538848375100453
8P23.1 MICRODELETION SYNDROME	0.006551453	0.24538848375100453
22Q11.2 MICRODUPLICATION SYNDROME	0.006551453	0.24538848375100453
10Q22.3Q23.3 MICRODELETION SYNDROME	0.006551453	0.24538848375100453
19P13.13 MICRODELETION SYNDROME	0.006551453	0.24538848375100453
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.006551453	0.24538848375100453
SMITH-MAGENIS SYNDROME	0.006551453	0.24538848375100453
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.006551453	0.24538848375100453
RUBINSTEIN-TAYBI SYNDROME	0.006551453	0.24538848375100453
48,XXYY SYNDROME	0.006551453	0.24538848375100453
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.006551453	0.24538848375100453
2Q37 MICRODELETION SYNDROME	0.006551453	0.24538848375100453
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.006551453	0.24538848375100453
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.006551453	0.24538848375100453
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.006551453	0.24538848375100453
DIGEORGE SYNDROME; DGS	0.006551453	0.24538848375100453
15Q24 MICRODELETION SYNDROME	0.006551453	0.24538848375100453
1Q21.1 MICRODUPLICATION SYNDROME	0.006551453	0.24538848375100453
DISTAL 16P11.2 MICRODELETION SYNDROME	0.006551453	0.24538848375100453
48,XXXY SYNDROME	0.006551453	0.24538848375100453
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.006551453	0.24538848375100453
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.006551453	0.24538848375100453
PRADER-WILLI SYNDROME; PWS	0.006551453	0.24538848375100453
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.006551453	0.24538848375100453
DISTAL MONOSOMY 15Q	0.006551453	0.24538848375100453
16P13.2 MICRODELETION SYNDROME	0.006551453	0.24538848375100453
MUENKE SYNDROME	0.006551453	0.24538848375100453
TRISOMY X	0.006551453	0.24538848375100453
DESANTO-SHINAWI SYNDROME	0.006551453	0.24538848375100453
11Q22.2Q22.3 MICRODELETION SYNDROME	0.006551453	0.24538848375100453
INCONTINENTIA PIGMENTI	0.006551453	0.24538848375100453
SIALURIA	0.006551453	0.24538848375100453
49,XXXXY SYNDROME	0.006551453	0.24538848375100453
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.006551453	0.24538848375100453
1Q21.1 MICRODELETION SYNDROME	0.006551453	0.24538848375100453
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.006551453	0.24538848375100453
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.006551453	0.24538848375100453
15Q13.3 MICRODELETION SYNDROME	0.006551453	0.24538848375100453
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.006551453	0.24538848375100453
SHUKLA-VERNON SYNDROME; SHUVER	0.006551453	0.24538848375100453
CLASSIC PHENYLKETONURIA	0.006551453	0.24538848375100453
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.006010034	0.2251093201083767
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.006010034	0.2251093201083767
OBESITY DUE TO SIM1 DEFICIENCY	0.006010034	0.2251093201083767
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.006010034	0.2251093201083767
CHARGE SYNDROME	0.006010034	0.2251093201083767
16P13.11 MICRODUPLICATION SYNDROME	0.006010034	0.2251093201083767
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.006010034	0.2251093201083767
AARSKOG-SCOTT SYNDROME	0.006010034	0.2251093201083767
17P11.2 MICRODUPLICATION SYNDROME	0.006010034	0.2251093201083767
3Q29 MICRODELETION SYNDROME	0.006010034	0.2251093201083767
17Q21.31 MICRODUPLICATION SYNDROME	0.006010034	0.2251093201083767
CHROMOSOME 15Q25 DELETION SYNDROME	0.006010034	0.2251093201083767
TRANSKETOLASE DEFICIENCY	0.006010034	0.2251093201083767
TURNPENNY-FRY SYNDROME; TPFS	0.006010034	0.2251093201083767
2Q32Q33 MICRODELETION SYNDROME	0.006010034	0.2251093201083767
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.006010034	0.2251093201083767
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.006010034	0.2251093201083767
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.006010034	0.2251093201083767
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.006010034	0.2251093201083767
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.006010034	0.2251093201083767
MARDEN-WALKER SYNDROME	0.006010034	0.2251093201083767
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.006010034	0.2251093201083767
COFFIN-SIRIS SYNDROME 6; CSS6	0.006010034	0.2251093201083767
2P15P16.1 MICRODELETION SYNDROME	0.006010034	0.2251093201083767
8Q12 MICRODUPLICATION SYNDROME	0.006010034	0.2251093201083767
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.006010034	0.2251093201083767
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.006010034	0.2251093201083767
47,XYY SYNDROME	0.006005899	0.2249544412776333
DUBOWITZ SYNDROME	0.006005899	0.2249544412776333
STURGE-WEBER SYNDROME	0.006005899	0.2249544412776333
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.006005899	0.2249544412776333
CYCLIC VOMITING SYNDROME	0.006005899	0.2249544412776333
OCULOCEREBRORENAL SYNDROME OF LOWE	0.006005899	0.2249544412776333
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.006005899	0.2249544412776333
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.006005899	0.2249544412776333
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.006005899	0.2249544412776333
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.006005899	0.2249544412776333
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.006005899	0.2249544412776333
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.006005899	0.2249544412776333
FRAGILE X SYNDROME	0.006005899	0.2249544412776333
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.006005899	0.2249544412776333
NEUROFIBROMATOSIS TYPE 1	0.006005899	0.2249544412776333
RABIES	0.006005899	0.2249544412776333
PHENYLKETONURIA	0.006005899	0.2249544412776333
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.00546448	0.20467527763500543
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.00546448	0.20467527763500543
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00546448	0.20467527763500543
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00546448	0.20467527763500543
TURNER SYNDROME	0.00546448	0.20467527763500543
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00546448	0.20467527763500543
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00546448	0.20467527763500543
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00546448	0.20467527763500543
ATTENTION DEFICIT-HYPERACTIVITY DISORDER	0.00546448	0.20467527763500543
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00546448	0.20467527763500543
MICROTIA	0.00546448	0.20467527763500543
16P12.1P12.3 TRIPLICATION SYNDROME	0.00546448	0.20467527763500543
MARFAN SYNDROME	0.00546448	0.20467527763500543
SPINOCEREBELLAR ATAXIA 14	0.00546448	0.20467527763500543
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00546448	0.20467527763500543
MOHR-TRANEBJAERG SYNDROME	0.00546448	0.20467527763500543
MOSAIC MONOSOMY X	0.00546448	0.20467527763500543
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00546448	0.20467527763500543
EARLY-ONSET SCHIZOPHRENIA	0.00546448	0.20467527763500543
MONOSOMY X	0.00546448	0.20467527763500543
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00546448	0.20467527763500543
TRISOMY 18P	0.00546448	0.20467527763500543
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.00546448	0.20467527763500543
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00546448	0.20467527763500543
NIJMEGEN BREAKAGE SYNDROME	0.00546448	0.20467527763500543
SCHWARTZ-JAMPEL SYNDROME	0.00546448	0.20467527763500543
X-LINKED ADRENOLEUKODYSTROPHY	0.00546448	0.20467527763500543
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.00546448	0.20467527763500543
LEGIUS SYNDROME	0.00546448	0.20467527763500543
RECESSIVE X-LINKED ICHTHYOSIS	0.00546448	0.20467527763500543
IMMUNODEFICIENCY 61; IMD61	0.00546448	0.20467527763500543
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.005397313000000001	0.2021594985722382
CHÃ‰DIAK-HIGASHI SYNDROME	0.005397313000000001	0.2021594985722382
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.005397313000000001	0.2021594985722382
NIEMANN-PICK DISEASE TYPE C	0.005397313000000001	0.2021594985722382
RING CHROMOSOME 22 SYNDROME	0.005397313000000001	0.2021594985722382
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.005397313000000001	0.2021594985722382
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.005397313000000001	0.2021594985722382
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.005397313000000001	0.2021594985722382
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.005397313000000001	0.2021594985722382
MUCOPOLYSACCHARIDOSIS TYPE 2	0.005397313000000001	0.2021594985722382
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.005397313000000001	0.2021594985722382
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.005397313000000001	0.2021594985722382
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.005397313000000001	0.2021594985722382
MULTIPLE SULFATASE DEFICIENCY	0.005397313000000001	0.2021594985722382
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.005397313000000001	0.2021594985722382
HSD10 DISEASE	0.005397313000000001	0.2021594985722382
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.005397313000000001	0.2021594985722382
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.005397313000000001	0.2021594985722382
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.005397313000000001	0.2021594985722382
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.005397313000000001	0.2021594985722382
AICARDI-GOUTIERES SYNDROME 7	0.005397313000000001	0.2021594985722382
OPTIC PATHWAY GLIOMA	0.005397313000000001	0.2021594985722382
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.005397313000000001	0.2021594985722382
KLEEFSTRA SYNDROME	0.005397313000000001	0.2021594985722382
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.005397313000000001	0.2021594985722382
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.005397313000000001	0.2021594985722382
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.005397313000000001	0.2021594985722382
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.005397313000000001	0.2021594985722382
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.005397313000000001	0.2021594985722382
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.005397313000000001	0.2021594985722382
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.005397313000000001	0.2021594985722382
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.005397313000000001	0.2021594985722382
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.005397313000000001	0.2021594985722382
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.005397313000000001	0.2021594985722382
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.005397313000000001	0.2021594985722382
AICARDI-GOUTIÃˆRES SYNDROME	0.005397313000000001	0.2021594985722382
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.005397313000000001	0.2021594985722382
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.005397313000000001	0.2021594985722382
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.005397313000000001	0.2021594985722382
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.005397313000000001	0.2021594985722382
ZTTK SYNDROME; ZTTKS	0.005397313000000001	0.2021594985722382
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.005397313000000001	0.2021594985722382
SCHINDLER DISEASE, TYPE I	0.005397313000000001	0.2021594985722382
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.005397313000000001	0.2021594985722382
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.005397313000000001	0.2021594985722382
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.005397313000000001	0.2021594985722382
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.005397313000000001	0.2021594985722382
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.005397313000000001	0.2021594985722382
CANAVAN DISEASE	0.005397313000000001	0.2021594985722382
TAY-SACHS DISEASE	0.005397313000000001	0.2021594985722382
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.005397313000000001	0.2021594985722382
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.005397313000000001	0.2021594985722382
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.005397313000000001	0.2021594985722382
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.005397313000000001	0.2021594985722382
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.005397313	0.2021594985722382
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.004855894	0.18188033492961034
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.004855894	0.18188033492961034
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.004855894	0.18188033492961034
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.004855894	0.18188033492961034
AICARDI-GOUTIERES SYNDROME 6	0.004855894	0.18188033492961034
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.004855894	0.18188033492961034
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.004855894	0.18188033492961034
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.004855894	0.18188033492961034
HYPERMANGANESEMIA WITH DYSTONIA 2	0.004855894	0.18188033492961034
CEREBROTENDINOUS XANTHOMATOSIS	0.004851759000000001	0.18172545609886695
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.004851759000000001	0.18172545609886695
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.004851759000000001	0.18172545609886695
FLYNN-AIRD SYNDROME	0.004851759000000001	0.18172545609886695
CHILDHOOD DISINTEGRATIVE DISORDER	0.004851759000000001	0.18172545609886695
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.004851759000000001	0.18172545609886695
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.004851759000000001	0.18172545609886695
NASU-HAKOLA DISEASE	0.004851759000000001	0.18172545609886695
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.004851759000000001	0.18172545609886695
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.004851759000000001	0.18172545609886695
DYSOSTEOSCLEROSIS	0.004851759000000001	0.18172545609886695
RETT SYNDROME, CONGENITAL VARIANT	0.004851759000000001	0.18172545609886695
CADASIL	0.004851759000000001	0.18172545609886695
ALEXANDER DISEASE	0.004851759000000001	0.18172545609886695
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.004851759000000001	0.18172545609886695
RETT SYNDROME; RTT	0.004851759000000001	0.18172545609886695
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.004851759000000001	0.18172545609886695
RETT SYNDROME	0.004851759000000001	0.18172545609886695
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.004851759000000001	0.18172545609886695
KRABBE DISEASE	0.004851759000000001	0.18172545609886695
SNEDDON SYNDROME	0.004851759000000001	0.18172545609886695
BEHÃ‡ET DISEASE	0.004851759000000001	0.18172545609886695
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.004851759000000001	0.18172545609886695
METACHROMATIC LEUKODYSTROPHY	0.004851759000000001	0.18172545609886695
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.004851759000000001	0.18172545609886695
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.004851759000000001	0.18172545609886695
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.004851759000000001	0.18172545609886695
14Q12 MICRODELETION SYNDROME	0.004851759000000001	0.18172545609886695
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.004851759000000001	0.18172545609886695
NEURONAL CEROID LIPOFUSCINOSIS	0.004851759000000001	0.18172545609886695
ASPARTYLGLUCOSAMINURIA; AGU	0.004851759000000001	0.18172545609886695
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.004851759000000001	0.18172545609886695
MUCOPOLYSACCHARIDOSIS TYPE 3	0.004851759000000001	0.18172545609886695
ATYPICAL RETT SYNDROME	0.004851759000000001	0.18172545609886695
MENKES DISEASE	0.004851759000000001	0.18172545609886695
DILATED CARDIOMYOPATHY WITH ATAXIA	0.004851759000000001	0.18172545609886695
ADIPOSIS DOLOROSA	0.004851759000000001	0.18172545609886695
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.004851759000000001	0.18172545609886695
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.004851759000000001	0.18172545609886695
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.004851759000000001	0.18172545609886695
WOLFRAM SYNDROME	0.004851759000000001	0.18172545609886695
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.004851759000000001	0.18172545609886695
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.004851759000000001	0.18172545609886695
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004851759000000001	0.18172545609886695
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.004851759000000001	0.18172545609886695
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.004851759000000001	0.18172545609886695
WHIPPLE DISEASE	0.004851759000000001	0.18172545609886695
INFANTILE NEUROAXONAL DYSTROPHY	0.004851759000000001	0.18172545609886695
TRIPLE A SYNDROME	0.004851759000000001	0.18172545609886695
XERODERMA PIGMENTOSUM	0.004851759000000001	0.18172545609886695
ALEXANDER DISEASE	0.004851759000000001	0.18172545609886695
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.004851759000000001	0.18172545609886695
FABRY DISEASE	0.004851759000000001	0.18172545609886695
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00431034	0.1614462924562391
HUNTINGTON DISEASE	0.00431034	0.1614462924562391
REFSUM DISEASE	0.00431034	0.1614462924562391
NEUROFERRITINOPATHY	0.00431034	0.1614462924562391
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.00431034	0.1614462924562391
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00431034	0.1614462924562391
TRISOMY 5P	0.00431034	0.1614462924562391
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00431034	0.1614462924562391
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00431034	0.1614462924562391
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00431034	0.1614462924562391
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00431034	0.1614462924562391
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00431034	0.1614462924562391
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00431034	0.1614462924562391
DYSOSTEOSCLEROSIS	0.00431034	0.1614462924562391
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00431034	0.1614462924562391
DOWN SYNDROME	0.00431034	0.1614462924562391
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.00431034	0.1614462924562391
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00431034	0.1614462924562391
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00431034	0.1614462924562391
ATAXIA WITH VITAMIN E DEFICIENCY	0.00431034	0.1614462924562391
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00431034	0.1614462924562391
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00431034	0.1614462924562391
ELEJALDE DISEASE	0.001086973	0.0407132061159991
CODAS SYNDROME	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001086973	0.0407132061159991
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.0407132061159991
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.0407132061159991
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.0407132061159991
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001086973	0.0407132061159991
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.0407132061159991
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.0407132061159991
OCULOECTODERMAL SYNDROME; OES	0.001086973	0.0407132061159991
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.0407132061159991
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001086973	0.0407132061159991
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.0407132061159991
MEND SYNDROME; MEND	0.001086973	0.0407132061159991
ALG11-CDG	0.001086973	0.0407132061159991
WOLF-HIRSCHHORN SYNDROME	0.001086973	0.0407132061159991
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.001086973	0.0407132061159991
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.001086973	0.0407132061159991
MIRAGE SYNDROME; MIRAGE	0.001086973	0.0407132061159991
BAND HETEROTOPIA; BH	0.001086973	0.0407132061159991
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.0407132061159991
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.001086973	0.0407132061159991
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.001086973	0.0407132061159991
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001086973	0.0407132061159991
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.001086973	0.0407132061159991
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.001086973	0.0407132061159991
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001086973	0.0407132061159991
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001086973	0.0407132061159991
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001086973	0.0407132061159991
OROFACIODIGITAL SYNDROME TYPE 6	0.001086973	0.0407132061159991
L1 SYNDROME	0.001086973	0.0407132061159991
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.0407132061159991
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.0407132061159991
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.001086973	0.0407132061159991
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.0407132061159991
HARTNUP DISORDER	0.001086973	0.0407132061159991
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.0407132061159991
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.0407132061159991
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.0407132061159991
TIMOTHY SYNDROME; TS	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.001086973	0.0407132061159991
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.0407132061159991
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001086973	0.0407132061159991
LISSENCEPHALY 8; LIS8	0.001086973	0.0407132061159991
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.001086973	0.0407132061159991
NARP SYNDROME	0.001086973	0.0407132061159991
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.0407132061159991
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.0407132061159991
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.0407132061159991
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001086973	0.0407132061159991
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.001086973	0.0407132061159991
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001086973	0.0407132061159991
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.0407132061159991
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001086973	0.0407132061159991
1P36 DELETION SYNDROME	0.001086973	0.0407132061159991
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001086973	0.0407132061159991
MONOSOMY 18Q	0.001086973	0.0407132061159991
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.0407132061159991
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.0407132061159991
LEBER CONGENITAL AMAUROSIS	0.001086973	0.0407132061159991
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.0407132061159991
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.0407132061159991
XQ25 MICRODUPLICATION SYNDROME	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001086973	0.0407132061159991
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.0407132061159991
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.0407132061159991
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.001086973	0.0407132061159991
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001086973	0.0407132061159991
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.001086973	0.0407132061159991
ALSTRÃ–M SYNDROME	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.0407132061159991
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.0407132061159991
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.0407132061159991
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.0407132061159991
AL KAISSI SYNDROME; ALKAS	0.001086973	0.0407132061159991
KETOADIPICACIDURIA	0.001086973	0.0407132061159991
WALKER-WARBURG SYNDROME	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.0407132061159991
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001086973	0.0407132061159991
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001086973	0.0407132061159991
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.0407132061159991
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001086973	0.0407132061159991
XQ21 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.0407132061159991
19P13.12 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.0407132061159991
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001086973	0.0407132061159991
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001086973	0.0407132061159991
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.0407132061159991
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.0407132061159991
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.001086973	0.0407132061159991
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001086973	0.0407132061159991
LATHOSTEROLOSIS	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.0407132061159991
MACDERMOT-WINTER SYNDROME	0.001086973	0.0407132061159991
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.001086973	0.0407132061159991
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.0407132061159991
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.0407132061159991
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001086973	0.0407132061159991
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.001086973	0.0407132061159991
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001086973	0.0407132061159991
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.0407132061159991
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.0407132061159991
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001086973	0.0407132061159991
3Q29 MICRODUPLICATION SYNDROME	0.001086973	0.0407132061159991
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001086973	0.0407132061159991
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001086973	0.0407132061159991
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001086973	0.0407132061159991
2Q31.1 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.001086973	0.0407132061159991
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.0407132061159991
WYBURN-MASON SYNDROME	0.001086973	0.0407132061159991
MICRO SYNDROME	0.001086973	0.0407132061159991
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.0407132061159991
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.0407132061159991
CRANIOPHARYNGIOMA	0.001086973	0.0407132061159991
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001086973	0.0407132061159991
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.0407132061159991
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.001086973	0.0407132061159991
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.0407132061159991
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.001086973	0.0407132061159991
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.001086973	0.0407132061159991
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.001086973	0.0407132061159991
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001086973	0.0407132061159991
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.0407132061159991
MAPLE SYRUP URINE DISEASE	0.001086973	0.0407132061159991
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.0407132061159991
GENITOPATELLAR SYNDROME	0.001086973	0.0407132061159991
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.0407132061159991
CK SYNDROME	0.001086973	0.0407132061159991
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.0407132061159991
6Q25 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
ARGININEMIA	0.001086973	0.0407132061159991
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.001086973	0.0407132061159991
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.001086973	0.0407132061159991
KEUTEL SYNDROME	0.001086973	0.0407132061159991
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.0407132061159991
PETTIGREW SYNDROME	0.001086973	0.0407132061159991
8P11.2 DELETION SYNDROME	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.0407132061159991
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001086973	0.0407132061159991
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.0407132061159991
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001086973	0.0407132061159991
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.001086973	0.0407132061159991
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001086973	0.0407132061159991
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001086973	0.0407132061159991
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.001086973	0.0407132061159991
SOTOS SYNDROME	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.001086973	0.0407132061159991
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.0407132061159991
VICI SYNDROME	0.001086973	0.0407132061159991
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.0407132061159991
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001086973	0.0407132061159991
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.0407132061159991
LEIGH SYNDROME; LS	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.0407132061159991
XP21 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
8Q24.3 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001086973	0.0407132061159991
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.001086973	0.0407132061159991
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001086973	0.0407132061159991
PFEIFFER SYNDROME TYPE 2	0.001086973	0.0407132061159991
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.0407132061159991
DUANE RETRACTION SYNDROME	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.001086973	0.0407132061159991
KBG SYNDROME	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001086973	0.0407132061159991
VICI SYNDROME; VICIS	0.001086973	0.0407132061159991
KLEEFSTRA SYNDROME 2; KLEFS2	0.001086973	0.0407132061159991
BARAITSER-WINTER SYNDROME 1; BRWS1	0.001086973	0.0407132061159991
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.0407132061159991
NETHERTON SYNDROME	0.001086973	0.0407132061159991
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.0407132061159991
XQ25 DUPLICATION SYNDROME	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.0407132061159991
20P12.3 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
PELIZAEUS-MERZBACHER DISEASE	0.001086973	0.0407132061159991
MONOSOMY 9P	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001086973	0.0407132061159991
COFFIN-SIRIS SYNDROME	0.001086973	0.0407132061159991
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.0407132061159991
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001086973	0.0407132061159991
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001086973	0.0407132061159991
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.001086973	0.0407132061159991
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.001086973	0.0407132061159991
WAISMAN SYNDROME; WSMN	0.001086973	0.0407132061159991
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001086973	0.0407132061159991
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.001086973	0.0407132061159991
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.0407132061159991
FREE SIALIC ACID STORAGE DISEASE	0.001086973	0.0407132061159991
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001086973	0.0407132061159991
WIEACKER-WOLFF SYNDROME	0.001086973	0.0407132061159991
CHROMOSOME 1P35 DELETION SYNDROME	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001086973	0.0407132061159991
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001086973	0.0407132061159991
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.0407132061159991
17Q12 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.0407132061159991
JABERI-ELAHI SYNDROME; JABELS	0.001086973	0.0407132061159991
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.001086973	0.0407132061159991
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001086973	0.0407132061159991
15Q14 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 104; MRX104	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.001086973	0.0407132061159991
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001086973	0.0407132061159991
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001086973	0.0407132061159991
2P21 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.001086973	0.0407132061159991
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.0407132061159991
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.001086973	0.0407132061159991
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001086973	0.0407132061159991
PYRUVATE DEHYDROGENASE DEFICIENCY	0.001086973	0.0407132061159991
KABUKI SYNDROME 1	0.001086973	0.0407132061159991
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.0407132061159991
KBG SYNDROME	0.001086973	0.0407132061159991
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.001086973	0.0407132061159991
COFFIN-SIRIS SYNDROME 2; CSS2	0.001086973	0.0407132061159991
COFFIN-SIRIS SYNDROME 3; CSS3	0.001086973	0.0407132061159991
COFFIN-SIRIS SYNDROME 4; CSS4	0.001086973	0.0407132061159991
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.0407132061159991
SPINOCEREBELLAR ATAXIA TYPE 13	0.001086973	0.0407132061159991
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.0407132061159991
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.0407132061159991
PONTINE TEGMENTAL CAP DYSPLASIA	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.0407132061159991
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.001086973	0.0407132061159991
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001086973	0.0407132061159991
6Q TERMINAL DELETION SYNDROME	0.001086973	0.0407132061159991
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.001086973	0.0407132061159991
PETERS-PLUS SYNDROME; PTRPLS	0.001086973	0.0407132061159991
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001086973	0.0407132061159991
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.0407132061159991
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001086973	0.0407132061159991
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001086973	0.0407132061159991
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.0407132061159991
ADAMS-OLIVER SYNDROME 2; AOS2	0.001086973	0.0407132061159991
INFANTILE REFSUM DISEASE	0.001086973	0.0407132061159991
EAST SYNDROME	0.001086973	0.0407132061159991
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.0407132061159991
EMANUEL SYNDROME	0.001086973	0.0407132061159991
WILSON-TURNER SYNDROME	0.001086973	0.0407132061159991
FUCOSIDOSIS	0.001086973	0.0407132061159991
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001086973	0.0407132061159991
MONOSOMY 22Q13.3	0.001086973	0.0407132061159991
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.0407132061159991
PALLISTER-HALL SYNDROME	0.001086973	0.0407132061159991
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.0407132061159991
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.0407132061159991
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.0407132061159991
DISTAL TRISOMY 17Q	0.001086973	0.0407132061159991
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.0407132061159991
GALACTOSEMIA	0.001086973	0.0407132061159991
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.0407132061159991
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.001086973	0.0407132061159991
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.0407132061159991
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001086973	0.0407132061159991
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.001086973	0.0407132061159991
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.0407132061159991
PEHO SYNDROME; PEHO	0.001086973	0.0407132061159991
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.001086973	0.0407132061159991
COHEN SYNDROME	0.001086973	0.0407132061159991
FILIPPI SYNDROME	0.001086973	0.0407132061159991
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001086973	0.0407132061159991
SRD5A3-CDG	0.001086973	0.0407132061159991
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.001086973	0.0407132061159991
ALG1-CDG	0.001086973	0.0407132061159991
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.0407132061159991
DYSTONIA-APHONIA SYNDROME	0.001086973	0.0407132061159991
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001086973	0.0407132061159991
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001086973	0.0407132061159991
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.0407132061159991
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.0407132061159991
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.0407132061159991
ISOVALERIC ACIDEMIA	0.001086973	0.0407132061159991
BOHRING-OPITZ SYNDROME	0.001086973	0.0407132061159991
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001086973	0.0407132061159991
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.0407132061159991
SULFOCYSTEINURIA	0.001086973	0.0407132061159991
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.0407132061159991
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.001086973	0.0407132061159991
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.001086973	0.0407132061159991
HOLOPROSENCEPHALY 2; HPE2	0.001086973	0.0407132061159991
PMM2-CDG	0.001086973	0.0407132061159991
SIALIDOSIS TYPE 2	0.001086973	0.0407132061159991
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001086973	0.0407132061159991
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001086973	0.0407132061159991
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001086973	0.0407132061159991
TETRASOMY 9P	0.001086973	0.0407132061159991
TETRASOMY 5P	0.001086973	0.0407132061159991
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.0407132061159991
HYDRANENCEPHALY	0.001086973	0.0407132061159991
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.0407132061159991
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.0407132061159991
ALG3-CDG	0.001086973	0.0407132061159991
NIEMANN-PICK DISEASE, TYPE C2	0.001086973	0.0407132061159991
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.0407132061159991
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.001086973	0.0407132061159991
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001086973	0.0407132061159991
ANGELMAN SYNDROME	0.001086973	0.0407132061159991
KOOLEN-DE VRIES SYNDROME; KDVS	0.001086973	0.0407132061159991
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.0407132061159991
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.0407132061159991
GRISCELLI SYNDROME	0.001086973	0.0407132061159991
SIMPSON-GOLABI-BEHMEL SYNDROME	0.001086973	0.0407132061159991
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.0407132061159991
GLASS SYNDROME	0.001086973	0.0407132061159991
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001086973	0.0407132061159991
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001086973	0.0407132061159991
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.0407132061159991
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.0407132061159991
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.001086973	0.0407132061159991
ADAMS-OLIVER SYNDROME 1; AOS1	0.001086973	0.0407132061159991
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.0407132061159991
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.001086973	0.0407132061159991
SSR4-CDG	0.001086973	0.0407132061159991
STT3B-CDG	0.001086973	0.0407132061159991
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001086973	0.0407132061159991
STT3A-CDG	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.0407132061159991
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001086973	0.0407132061159991
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001086973	0.0407132061159991
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.0407132061159991
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.0407132061159991
POTOCKI-SHAFFER SYNDROME	0.001086973	0.0407132061159991
POTOCKI-LUPSKI SYNDROME	0.001086973	0.0407132061159991
HOLOPROSENCEPHALY 7	0.001086973	0.0407132061159991
CORNELIA DE LANGE SYNDROME 3	0.001086973	0.0407132061159991
MAN1B1-CDG	0.001086973	0.0407132061159991
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.0407132061159991
HARTNUP DISEASE	0.001086973	0.0407132061159991
611961 STEVENSON-CAREY SYNDROME	0.001086973	0.0407132061159991
XQ28 (MECP2) DUPLICATION	0.001086973	0.0407132061159991
CHROMOSOME 16P13.3 DELETION SYNDROME	0.001086973	0.0407132061159991
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.0407132061159991
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.001086973	0.0407132061159991
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.0407132061159991
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001086973	0.0407132061159991
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.0407132061159991
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.001086973	0.0407132061159991
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.0407132061159991
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.0407132061159991
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001086973	0.0407132061159991
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.0407132061159991
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.0407132061159991
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.0407132061159991
MONOSOMY 9Q22.3	0.001086973	0.0407132061159991
MEND SYNDROME	0.001086973	0.0407132061159991
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.001086973	0.0407132061159991
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.0407132061159991
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.001086973	0.0407132061159991
HOLOPROSENCEPHALY	0.001086973	0.0407132061159991
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.001086973	0.0407132061159991
CHROMOSOME 10Q26 DELETION SYNDROME	0.001086973	0.0407132061159991
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.0407132061159991
COFFIN-SIRIS SYNDROME 1; CSS1	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001086973	0.0407132061159991
LISSENCEPHALY 4	0.001086973	0.0407132061159991
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.0407132061159991
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001086973	0.0407132061159991
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.0407132061159991
COWDEN SYNDROME	0.001086973	0.0407132061159991
MYHRE SYNDROME	0.001086973	0.0407132061159991
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001086973	0.0407132061159991
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001086973	0.0407132061159991
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.0407132061159991
JOUBERT SYNDROME	0.001086973	0.0407132061159991
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.0407132061159991
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.001086973	0.0407132061159991
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001086973	0.0407132061159991
HERNÃNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.0407132061159991
DONNAI-BARROW SYNDROME	0.001086973	0.0407132061159991
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.0407132061159991
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.0407132061159991
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001086973	0.0407132061159991
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.0407132061159991
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.0407132061159991
CHROMOSOME 19P13.13 DELETION SYNDROME	0.001086973	0.0407132061159991
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.0407132061159991
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.001086973	0.0407132061159991
DISTAL MONOSOMY 1Q	0.001086973	0.0407132061159991
20Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.0407132061159991
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.0407132061159991
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.001086973	0.0407132061159991
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001086973	0.0407132061159991
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001086973	0.0407132061159991
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001086973	0.0407132061159991
BOHRING-OPITZ SYNDROME	0.001086973	0.0407132061159991
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001086973	0.0407132061159991
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.0407132061159991
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.0407132061159991
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.0407132061159991
MOSAIC TRISOMY 14	0.001086973	0.0407132061159991
CITRULLINEMIA, CLASSIC	0.001086973	0.0407132061159991
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.0407132061159991
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.0407132061159991
COACH SYNDROME	0.001086973	0.0407132061159991
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.001086973	0.0407132061159991
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.0407132061159991
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001086973	0.0407132061159991
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.0407132061159991
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.001086973	0.0407132061159991
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001086973	0.0407132061159991
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.0407132061159991
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.0407132061159991
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.0407132061159991
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.001086973	0.0407132061159991
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.001086973	0.0407132061159991
GRISCELLI SYNDROME TYPE 1	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.0407132061159991
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.001086973	0.0407132061159991
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.0407132061159991
WIEDEMANN-STEINER SYNDROME; WDSTS	0.001086973	0.0407132061159991
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.0407132061159991
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.0407132061159991
PRADER-WILLI-LIKE SYNDROME	0.001086973	0.0407132061159991
JOUBERT SYNDROME WITH OCULAR DEFECT	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.0407132061159991
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.0407132061159991
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.001086973	0.0407132061159991
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.001086973	0.0407132061159991
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.0407132061159991
SALLA DISEASE	0.001086973	0.0407132061159991
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.0407132061159991
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.0407132061159991
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.0407132061159991
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.001086973	0.0407132061159991
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001086973	0.0407132061159991
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.0407132061159991
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.0407132061159991
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.001086973	0.0407132061159991
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.0407132061159991
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001086973	0.0407132061159991
GAUCHER DISEASE, TYPE II	0.001086973	0.0407132061159991
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001086973	0.0407132061159991
HEART AND BRAIN MALFORMATION SYNDROME	0.001086973	0.0407132061159991
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.0407132061159991
COFFIN-SIRIS SYNDROME 5	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.0407132061159991
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.0407132061159991
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001086973	0.0407132061159991
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.0407132061159991
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001086973	0.0407132061159991
CHROMOSOME 16P13.2 DELETION SYNDROME	0.001086973	0.0407132061159991
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001086973	0.0407132061159991
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.0407132061159991
MEVALONIC ACIDURIA	0.001086973	0.0407132061159991
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.0407132061159991
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.0407132061159991
PITT-HOPKINS SYNDROME	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.001086973	0.0407132061159991
CEDNIK SYNDROME	0.001086973	0.0407132061159991
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.001086973	0.0407132061159991
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.001086973	0.0407132061159991
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001086973	0.0407132061159991
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001086973	0.0407132061159991
TARP SYNDROME	0.001086973	0.0407132061159991
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.0407132061159991
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001086973	0.0407132061159991
SCHIZENCEPHALY	0.001086973	0.0407132061159991
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.0407132061159991
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.001086973	0.0407132061159991
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.0407132061159991
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.0407132061159991
PHELAN-MCDERMID SYNDROME	0.001086973	0.0407132061159991
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001086973	0.0407132061159991
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.001086973	0.0407132061159991
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.0407132061159991
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.0407132061159991
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001086973	0.0407132061159991
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.001086973	0.0407132061159991
KOOLEN-DE VRIES SYNDROME	0.001086973	0.0407132061159991
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001086973	0.0407132061159991
SEVERE CANAVAN DISEASE	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001086973	0.0407132061159991
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.0407132061159991
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.0407132061159991
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001086973	0.0407132061159991
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.0407132061159991
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.0407132061159991
PHACE SYNDROME	0.001086973	0.0407132061159991
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.0407132061159991
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.0407132061159991
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001086973	0.0407132061159991
SMITH-MAGENIS SYNDROME; SMS	0.001086973	0.0407132061159991
JOUBERT SYNDROME WITH RENAL DEFECT	0.001086973	0.0407132061159991
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.0407132061159991
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.0407132061159991
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001086973	0.0407132061159991
INFANTILE LIVER FAILURE SYNDROME 1	0.001086973	0.0407132061159991
MATERNAL PHENYLKETONURIA	0.001086973	0.0407132061159991
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001086973	0.0407132061159991
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.0407132061159991
WEAVER SYNDROME	0.001086973	0.0407132061159991
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.0407132061159991
DPAGT1-CDG	0.001086973	0.0407132061159991
PHACE ASSOCIATION	0.001086973	0.0407132061159991
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.0407132061159991
SCHAAF-YANG SYNDROME; SHFYNG	0.001086973	0.0407132061159991
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001086973	0.0407132061159991
HELSMOORTEL-VAN DER AA SYNDROME	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001086973	0.0407132061159991
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.001086973	0.0407132061159991
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.0407132061159991
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.0407132061159991
MEHMO SYNDROME; MEHMO	0.001086973	0.0407132061159991
DISTAL MONOSOMY 19P13.3	0.001086973	0.0407132061159991
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001086973	0.0407132061159991
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.0407132061159991
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.0407132061159991
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.0407132061159991
C SYNDROME	0.001086973	0.0407132061159991
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.0407132061159991
ARGININOSUCCINIC ACIDURIA	0.001086973	0.0407132061159991
RUVALCABA SYNDROME	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001086973	0.0407132061159991
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001086973	0.0407132061159991
PROPIONIC ACIDEMIA	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.0407132061159991
RECOMBINANT 8 SYNDROME	0.001086973	0.0407132061159991
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.0407132061159991
CATEL-MANZKE SYNDROME; CATMANS	0.001086973	0.0407132061159991
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.0407132061159991
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.0407132061159991
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.001086973	0.0407132061159991
NETHERTON SYNDROME; NETH	0.000545554	0.020434042473371255
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.020434042473371255
NAVAJO NEUROHEPATOPATHY	0.000545554	0.020434042473371255
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.020434042473371255
ZECHI-CEIDE SYNDROME	0.000545554	0.020434042473371255
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.020434042473371255
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.020434042473371255
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.020434042473371255
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.020434042473371255
PELLAGRA-LIKE SYNDROME	0.000545554	0.020434042473371255
USHER SYNDROME TYPE 1	0.000545554	0.020434042473371255
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.020434042473371255
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.020434042473371255
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.020434042473371255
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.020434042473371255
TRISOMY 9P	0.000545554	0.020434042473371255
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
MICROVILLUS INCLUSION DISEASE	0.000545554	0.020434042473371255
HYPERTRICHOSIS CUBITI	0.000545554	0.020434042473371255
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.020434042473371255
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.020434042473371255
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.020434042473371255
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020434042473371255
CHAR SYNDROME	0.000545554	0.020434042473371255
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.020434042473371255
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020434042473371255
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.020434042473371255
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.020434042473371255
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.020434042473371255
OROTIC ACIDURIA	0.000545554	0.020434042473371255
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.020434042473371255
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.020434042473371255
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.000545554	0.020434042473371255
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.020434042473371255
ICF SYNDROME	0.000545554	0.020434042473371255
RAINE SYNDROME	0.000545554	0.020434042473371255
3MC SYNDROME 2	0.000545554	0.020434042473371255
TETRASOMY X	0.000545554	0.020434042473371255
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.020434042473371255
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.020434042473371255
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.020434042473371255
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.020434042473371255
HEREDITARY OROTIC ACIDURIA	0.000545554	0.020434042473371255
CEREBROFACIOARTICULAR SYNDROME	0.000545554	0.020434042473371255
SENIOR-LOKEN SYNDROME	0.000545554	0.020434042473371255
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.020434042473371255
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.020434042473371255
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.020434042473371255
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.020434042473371255
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.020434042473371255
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.020434042473371255
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.020434042473371255
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020434042473371255
SEPTOOPTIC DYSPLASIA	0.000545554	0.020434042473371255
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.000545554	0.020434042473371255
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.020434042473371255
ABETAL34V AMYLOIDOSIS	0.000545554	0.020434042473371255
CURRARINO SYNDROME	0.000545554	0.020434042473371255
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.020434042473371255
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.020434042473371255
ZEBRA BODY MYOPATHY	0.000545554	0.020434042473371255
RIGID SPINE SYNDROME	0.000545554	0.020434042473371255
ALSTROM SYNDROME; ALMS	0.000545554	0.020434042473371255
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.020434042473371255
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.020434042473371255
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.020434042473371255
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.020434042473371255
JOUBERT SYNDROME 1	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.020434042473371255
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
THYROID HEMIAGENESIS	0.000545554	0.020434042473371255
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.020434042473371255
THYROID HYPOPLASIA	0.000545554	0.020434042473371255
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.020434042473371255
DISTAL MONOSOMY 6P	0.000545554	0.020434042473371255
BARDET-BIEDL SYNDROME 1; BBS1	0.000545554	0.020434042473371255
MONOSOMY 13Q34	0.000545554	0.020434042473371255
AUSTRALIA ANTIGEN	0.000545554	0.020434042473371255
OXOGLUTARIC ACIDURIA	0.000545554	0.020434042473371255
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.020434042473371255
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.000545554	0.020434042473371255
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.020434042473371255
SAY-BARBER-MILLER SYNDROME	0.000545554	0.020434042473371255
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.020434042473371255
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.020434042473371255
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.020434042473371255
CHAR SYNDROME	0.000545554	0.020434042473371255
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020434042473371255
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.020434042473371255
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.020434042473371255
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.020434042473371255
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.020434042473371255
MOSAIC TRISOMY 9	0.000545554	0.020434042473371255
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.020434042473371255
LIG4 SYNDROME	0.000545554	0.020434042473371255
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.020434042473371255
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.020434042473371255
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.000545554	0.020434042473371255
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.020434042473371255
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.020434042473371255
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.020434042473371255
8P23.1 DUPLICATION SYNDROME	0.000545554	0.020434042473371255
12Q14 MICRODELETION SYNDROME	0.000545554	0.020434042473371255
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.020434042473371255
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.020434042473371255
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.000545554	0.020434042473371255
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
48,XYYY SYNDROME	0.000545554	0.020434042473371255
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.020434042473371255
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.020434042473371255
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.020434042473371255
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.020434042473371255
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.020434042473371255
FARBER DISEASE	0.000545554	0.020434042473371255
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.020434042473371255
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.020434042473371255
TRISOMY 18	0.000545554	0.020434042473371255
WEAVER SYNDROME	0.000545554	0.020434042473371255
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.020434042473371255
YUNIS-VARON SYNDROME	0.000545554	0.020434042473371255
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000545554	0.020434042473371255
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.020434042473371255
PROPIONIC ACIDEMIA	0.000545554	0.020434042473371255
ISOLATED PLAGIOCEPHALY	0.000545554	0.020434042473371255
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.020434042473371255
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.020434042473371255
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.020434042473371255
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.020434042473371255
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.020434042473371255
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.000545554	0.020434042473371255
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.020434042473371255
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.020434042473371255
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.020434042473371255
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.020434042473371255
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.020434042473371255
16P11.2P12.2 MICRODELETION SYNDROME	0.000545554	0.020434042473371255
TRISOMY 17P	0.000545554	0.020434042473371255
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.020434042473371255
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.020434042473371255
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.020434042473371255
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.020434042473371255
ARIMA SYNDROME	0.000545554	0.020434042473371255
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.020434042473371255
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.020434042473371255
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.020434042473371255
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.020434042473371255
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.020434042473371255
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.020434042473371255
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.020434042473371255
HURLER SYNDROME	0.000545554	0.020434042473371255
HYDROXYKYNURENINURIA	0.000545554	0.020434042473371255
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.020434042473371255
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.020434042473371255
N SYNDROME	0.000545554	0.020434042473371255
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.020434042473371255
MIETENS SYNDROME	0.000545554	0.020434042473371255
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.020434042473371255
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
MUCOLIPIDOSIS IV; ML4	0.000545554	0.020434042473371255
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.020434042473371255
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.020434042473371255
JAWAD SYNDROME	0.000545554	0.020434042473371255
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.000545554	0.020434042473371255
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.020434042473371255
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.020434042473371255
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.020434042473371255
EAR-PATELLA-SHORT STATURE SYNDROME	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.020434042473371255
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000545554	0.020434042473371255
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.020434042473371255
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.020434042473371255
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.020434042473371255
MARINESCO-SJOGREN SYNDROME; MSS	0.000545554	0.020434042473371255
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.020434042473371255
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000545554	0.020434042473371255
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.020434042473371255
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.020434042473371255
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.020434042473371255
OKAMOTO SYNDROME	0.000545554	0.020434042473371255
CONGENITAL VARICELLA SYNDROME	0.000545554	0.020434042473371255
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.020434042473371255
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.020434042473371255
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.020434042473371255
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.020434042473371255
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.020434042473371255
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.020434042473371255
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.020434042473371255
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.020434042473371255
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.020434042473371255
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020434042473371255
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.020434042473371255
1P21.3 MICRODELETION SYNDROME	0.000545554	0.020434042473371255
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.020434042473371255
THYROID ECTOPIA	0.000545554	0.020434042473371255
DE BARSY SYNDROME	0.000545554	0.020434042473371255
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.020434042473371255
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.020434042473371255
ATHYREOSIS	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.020434042473371255
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020434042473371255
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.000545554	0.020434042473371255
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.020434042473371255
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.020434042473371255
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.000545554	0.020434042473371255
OPITZ G/BBB SYNDROME	0.000545554	0.020434042473371255
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.020434042473371255
OROFACIODIGITAL SYNDROME TYPE 4	0.000545554	0.020434042473371255
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.020434042473371255
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.020434042473371255
OGDEN SYNDROME	0.000545554	0.020434042473371255
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.020434042473371255
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.020434042473371255
CONGENITAL HYPOTHYROIDISM	0.000545554	0.020434042473371255
LATERAL MENINGOCELE SYNDROME	0.000545554	0.020434042473371255
OTOFACIOCERVICAL SYNDROME	0.000545554	0.020434042473371255
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.020434042473371255
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.020434042473371255
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.020434042473371255
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.020434042473371255
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.020434042473371255
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.020434042473371255
HOLMES-GANG SYNDROME	0.000545554	0.020434042473371255
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.020434042473371255
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.020434042473371255
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.020434042473371255
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020434042473371255
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020434042473371255
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.020434042473371255
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.020434042473371255
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.020434042473371255
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.020434042473371255
FRONTOOCULAR SYNDROME	0.000545554	0.020434042473371255
PETERS PLUS SYNDROME	0.000545554	0.020434042473371255
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.020434042473371255
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.020434042473371255
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.020434042473371255
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.020434042473371255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.020434042473371255
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.020434042473371255
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.020434042473371255
NOONAN SYNDROME 2; NS2	0.000545554	0.020434042473371255
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.020434042473371255
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.020434042473371255
3C SYNDROME	0.000545554	0.020434042473371255
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.020434042473371255
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.020434042473371255
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.020434042473371255
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.020434042473371255
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.020434042473371255
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.020434042473371255
BARDET-BIEDL SYNDROME 2	0.000545554	0.020434042473371255
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.020434042473371255
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.000545554	0.020434042473371255
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.020434042473371255
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.020434042473371255
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.020434042473371255
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.020434042473371255
JOUBERT SYNDROME 21	0.000545554	0.020434042473371255
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.020434042473371255
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.020434042473371255
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020434042473371255
GENITOPATELLAR SYNDROME; GTPTS	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.020434042473371255
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.020434042473371255
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.020434042473371255
DESBUQUOIS DYSPLASIA 2; DBQD2	0.000545554	0.020434042473371255
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.020434042473371255
SECKEL SYNDROME 8; SCKL8	0.000545554	0.020434042473371255
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.020434042473371255
XIA-GIBBS SYNDROME	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.000545554	0.020434042473371255
CULLER-JONES SYNDROME; CJS	0.000545554	0.020434042473371255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.020434042473371255
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.020434042473371255
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.020434042473371255
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.020434042473371255
CHOPS SYNDROME; CHOPS	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000545554	0.020434042473371255
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.000545554	0.020434042473371255
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.020434042473371255
LAMB-SHAFFER SYNDROME	0.000545554	0.020434042473371255
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.020434042473371255
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.020434042473371255
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.020434042473371255
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.020434042473371255
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.020434042473371255
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020434042473371255
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.020434042473371255
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000545554	0.020434042473371255
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.020434042473371255
CURRY-JONES SYNDROME	0.000545554	0.020434042473371255
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.020434042473371255
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000545554	0.020434042473371255
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.020434042473371255
AL-RAQAD SYNDROME; ARS	0.000545554	0.020434042473371255
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.020434042473371255
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.020434042473371255
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.000545554	0.020434042473371255
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.020434042473371255
MEIER-GORLIN SYNDROME 7	0.000545554	0.020434042473371255
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.020434042473371255
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.020434042473371255
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.020434042473371255
JOUBERT SYNDROME 27	0.000545554	0.020434042473371255
JOUBERT SYNDROME 28	0.000545554	0.020434042473371255
ALAZAMI-YUAN SYNDROME	0.000545554	0.020434042473371255
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.020434042473371255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.020434042473371255
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000545554	0.020434042473371255
JOUBERT SYNDROME 26	0.000545554	0.020434042473371255
JOUBERT SYNDROME 25	0.000545554	0.020434042473371255
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.020434042473371255
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.020434042473371255
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.020434042473371255
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.020434042473371255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.020434042473371255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.020434042473371255
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.000545554	0.020434042473371255
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.020434042473371255
NOONAN SYNDROME 9; NS9	0.000545554	0.020434042473371255
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.000545554	0.020434042473371255
AU-KLINE SYNDROME; AUKS	0.000545554	0.020434042473371255
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.020434042473371255
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.020434042473371255
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.000545554	0.020434042473371255
SENIOR-LOKEN SYNDROME 9	0.000545554	0.020434042473371255
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.020434042473371255
JOUBERT SYNDROME 24	0.000545554	0.020434042473371255
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.020434042473371255
CDAGS SYNDROME	0.000545554	0.020434042473371255
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.020434042473371255
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.000545554	0.020434042473371255
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.020434042473371255
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.020434042473371255
SECKEL SYNDROME 9; SCKL9	0.000545554	0.020434042473371255
LIG4 SYNDROME	0.000545554	0.020434042473371255
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.020434042473371255
HURLER SYNDROME	0.000545554	0.020434042473371255
NOONAN SYNDROME 3; NS3	0.000545554	0.020434042473371255
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.020434042473371255
WARSAW BREAKAGE SYNDROME; WABS	0.000545554	0.020434042473371255
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.020434042473371255
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.020434042473371255
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.020434042473371255
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.020434042473371255
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.020434042473371255
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.020434042473371255
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.020434042473371255
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000545554	0.020434042473371255
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.020434042473371255
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000545554	0.020434042473371255
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.000545554	0.020434042473371255
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.020434042473371255
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.020434042473371255
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.020434042473371255
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.020434042473371255
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.020434042473371255
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000545554	0.020434042473371255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.020434042473371255
FRIAS SYNDROME	0.000545554	0.020434042473371255
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.020434042473371255
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.020434042473371255
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.020434042473371255
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.020434042473371255
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.020434042473371255
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.020434042473371255
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.020434042473371255
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.020434042473371255
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.020434042473371255
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.020434042473371255
NOONAN SYNDROME 6; NS6	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.020434042473371255
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.020434042473371255
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020434042473371255
NOONAN SYNDROME 5; NS5	0.000545554	0.020434042473371255
JOUBERT SYNDROME 7	0.000545554	0.020434042473371255
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.020434042473371255
JOUBERT SYNDROME 6	0.000545554	0.020434042473371255
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.020434042473371255
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.020434042473371255
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.020434042473371255
HYDROXYKYNURENINURIA	0.000545554	0.020434042473371255
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.020434042473371255
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.020434042473371255
JOUBERT SYNDROME 8	0.000545554	0.020434042473371255
MEVALONIC ACIDURIA; MEVA	0.000545554	0.020434042473371255
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.020434042473371255
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.020434042473371255
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.000545554	0.020434042473371255
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.020434042473371255
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.020434042473371255
HADZISELIMOVIC SYNDROME	0.000545554	0.020434042473371255
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.020434042473371255
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.020434042473371255
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.020434042473371255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.020434042473371255
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.020434042473371255
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000545554	0.020434042473371255
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.020434042473371255
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.020434042473371255
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.020434042473371255
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.020434042473371255
JOUBERT SYNDROME 2	0.000545554	0.020434042473371255
ALG6-CDG	0.000545554	0.020434042473371255
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.020434042473371255
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.000545554	0.020434042473371255
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000545554	0.020434042473371255
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.020434042473371255
ALAZAMI SYNDROME; ALAZS	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.020434042473371255
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.020434042473371255
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.020434042473371255
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.020434042473371255
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.020434042473371255
STEEL SYNDROME; STLS	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.020434042473371255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.020434042473371255
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.020434042473371255
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020434042473371255
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020434042473371255
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.020434042473371255
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.020434042473371255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.020434042473371255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.020434042473371255
HARTSFIELD SYNDROME; HRTFDS	0.000545554	0.020434042473371255
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.000545554	0.020434042473371255
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.020434042473371255
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.020434042473371255
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.020434042473371255
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.020434042473371255
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.020434042473371255
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.020434042473371255
HOLOPROSENCEPHALY 11	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.020434042473371255
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.020434042473371255
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.020434042473371255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.020434042473371255
RABSON-MENDENHALL SYNDROME	0.000545554	0.020434042473371255
JOUBERT SYNDROME 14	0.000545554	0.020434042473371255
JOUBERT SYNDROME 15	0.000545554	0.020434042473371255
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.020434042473371255
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.020434042473371255
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.020434042473371255
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.020434042473371255
LARSEN-LIKE SYNDROME	0.000545554	0.020434042473371255
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.020434042473371255
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.020434042473371255
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000545554	0.020434042473371255
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.020434042473371255
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.020434042473371255
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.020434042473371255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.020434042473371255
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.020434042473371255
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.020434042473371255
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.020434042473371255
WOLMAN DISEASE	0.000545554	0.020434042473371255
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.020434042473371255
EVEN-PLUS SYNDROME	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.000545554	0.020434042473371255
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.020434042473371255
TRANSALDOLASE DEFICIENCY	0.000545554	0.020434042473371255
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.020434042473371255
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.020434042473371255
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.020434042473371255
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
PENTASOMY X	0.000545554	0.020434042473371255
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.020434042473371255
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.020434042473371255
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.020434042473371255
TONNE-KALSCHEUER SYNDROME; TOKAS	0.000545554	0.020434042473371255
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.020434042473371255
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.020434042473371255
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.020434042473371255
AURICULOCONDYLAR SYNDROME	0.000545554	0.020434042473371255
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.020434042473371255
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.020434042473371255
BARATELA-SCOTT SYNDROME	0.000545554	0.020434042473371255
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.020434042473371255
RING CHROMOSOME 12 SYNDROME	0.000545554	0.020434042473371255
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.020434042473371255
OGDEN SYNDROME; OGDNS	0.000545554	0.020434042473371255
CODAS SYNDROME	0.000545554	0.020434042473371255
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.020434042473371255
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.020434042473371255
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.020434042473371255
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.020434042473371255
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020434042473371255
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.000545554	0.020434042473371255
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.020434042473371255
FANCONI ANEMIA	0.000545554	0.020434042473371255
SYNDROMIC DIARRHEA	0.000545554	0.020434042473371255
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.020434042473371255
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.000545554	0.020434042473371255
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.020434042473371255
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000545554	0.020434042473371255
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.020434042473371255
ATELOSTEOGENESIS TYPE III	0.000545554	0.020434042473371255
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.020434042473371255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.020434042473371255
MARINESCO-SJÃ–GREN SYNDROME	0.000545554	0.020434042473371255
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.020434042473371255
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.020434042473371255
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.020434042473371255
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.020434042473371255
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.020434042473371255
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.020434042473371255
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.000545554	0.020434042473371255
CRANIOFRONTONASAL SYNDROME; CFNS	0.000545554	0.020434042473371255
NOONAN SYNDROME 11; NS11	0.000545554	0.020434042473371255
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.020434042473371255
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.020434042473371255
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.020434042473371255
JOUBERT SYNDROME 10	0.000545554	0.020434042473371255
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020434042473371255
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.020434042473371255
BRESEK SYNDROME	0.000545554	0.020434042473371255
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.020434042473371255
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.020434042473371255
TOLUENE EMBRYOPATHY	0.000545554	0.020434042473371255
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.020434042473371255
OROFACIODIGITAL SYNDROME VI	0.000545554	0.020434042473371255
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.020434042473371255
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020434042473371255
OCCIPITAL HORN SYNDROME	0.000545554	0.020434042473371255
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.020434042473371255
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.020434042473371255
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.000545554	0.020434042473371255
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.020434042473371255
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.020434042473371255
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.020434042473371255
FLOATING-HARBOR SYNDROME	0.000545554	0.020434042473371255
ROTHMUND-THOMSON SYNDROME	0.000545554	0.020434042473371255
COLE-CARPENTER SYNDROME	0.000545554	0.020434042473371255
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.020434042473371255
REVESZ SYNDROME	0.000545554	0.020434042473371255
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.020434042473371255
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.020434042473371255
GERMAN SYNDROME	0.000545554	0.020434042473371255
GERODERMA OSTEODYSPLASTICA	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.020434042473371255
CUTIS LAXA	0.000545554	0.020434042473371255
BRAIN-LUNG-THYROID SYNDROME	0.000545554	0.020434042473371255
FETAL ALCOHOL SYNDROME	0.000545554	0.020434042473371255
WAARDENBURG-SHAH SYNDROME	0.000545554	0.020434042473371255
FETAL TRIMETHADIONE SYNDROME	0.000545554	0.020434042473371255
TRISOMY 12P	0.000545554	0.020434042473371255
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000545554	0.020434042473371255
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.020434042473371255
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.020434042473371255
MONOSOMY 18P	0.000545554	0.020434042473371255
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.020434042473371255
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.020434042473371255
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.020434042473371255
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.020434042473371255
DISTAL MONOSOMY 9P	0.000545554	0.020434042473371255
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.000545554	0.020434042473371255
DEXTROCARDIA	0.000545554	0.020434042473371255
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.000545554	0.020434042473371255
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.020434042473371255
FETAL HYDANTOIN SYNDROME	0.000545554	0.020434042473371255
DISTAL TRISOMY 18Q	0.000545554	0.020434042473371255
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.020434042473371255
6Q16 MICRODELETION SYNDROME	0.000545554	0.020434042473371255
DISTAL TRISOMY 6P	0.000545554	0.020434042473371255
TRISOMY 8Q	0.000545554	0.020434042473371255
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.020434042473371255
FRIED SYNDROME	0.000545554	0.020434042473371255
DYSKERATOSIS CONGENITA	0.000545554	0.020434042473371255
TEMTAMY SYNDROME	0.000545554	0.020434042473371255
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.020434042473371255
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.020434042473371255
TREACHER-COLLINS SYNDROME	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.020434042473371255
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.020434042473371255
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.020434042473371255
ALPHA-MANNOSIDOSIS	0.000545554	0.020434042473371255
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.020434042473371255
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.020434042473371255
MECKEL SYNDROME 13; MKS13	0.000545554	0.020434042473371255
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.020434042473371255
MEDULLOBLASTOMA	0.000545554	0.020434042473371255
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.020434042473371255
RAHMAN SYNDROME	0.000545554	0.020434042473371255
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.020434042473371255
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.020434042473371255
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.020434042473371255
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.020434042473371255
LOWRY-MACLEAN SYNDROME	0.000545554	0.020434042473371255
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.020434042473371255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.020434042473371255
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.020434042473371255
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020434042473371255
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.020434042473371255
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000545554	0.020434042473371255
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000545554	0.020434042473371255
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000545554	0.020434042473371255
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.020434042473371255
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.020434042473371255
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.020434042473371255
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.020434042473371255
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.020434042473371255
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.020434042473371255
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.020434042473371255
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000545554	0.020434042473371255
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.020434042473371255
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.020434042473371255
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.020434042473371255
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.020434042473371255
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.020434042473371255
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.020434042473371255
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.020434042473371255
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000545554	0.020434042473371255
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.000545554	0.020434042473371255
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.020434042473371255
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.020434042473371255
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.020434042473371255
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.020434042473371255
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000545554	0.020434042473371255
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.020434042473371255
COFFIN-SIRIS SYNDROME 7; CSS7	0.000545554	0.020434042473371255
BAKER-GORDON SYNDROME; BAGOS	0.000545554	0.020434042473371255
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.020434042473371255
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000545554	0.020434042473371255
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.020434042473371255
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000545554	0.020434042473371255
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.020434042473371255
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.020434042473371255
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.020434042473371255
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.020434042473371255
OPTIC ATROPHY 11; OPA11	0.000545554	0.020434042473371255
TARP SYNDROME; TARPS	0.000545554	0.020434042473371255
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.020434042473371255
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.020434042473371255
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.020434042473371255
SECONDARY SYRINGOMYELIA	0.000541419	0.020279163642627846
NEVUS COMEDONICUS SYNDROME	0.000541419	0.020279163642627846
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020279163642627846
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020279163642627846
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020279163642627846
SIALIDOSIS TYPE 1	0.000541419	0.020279163642627846
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.020279163642627846
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.020279163642627846
ISOLATED SPINA BIFIDA	0.000541419	0.020279163642627846
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.020279163642627846
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020279163642627846
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.020279163642627846
SJÃ–GREN-LARSSON SYNDROME	0.000541419	0.020279163642627846
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.000541419	0.020279163642627846
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020279163642627846
SANDHOFF DISEASE	0.000541419	0.020279163642627846
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.020279163642627846
KALLMANN SYNDROME	0.000541419	0.020279163642627846
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.020279163642627846
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.020279163642627846
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.020279163642627846
NIPAH VIRUS DISEASE	0.000541419	0.020279163642627846
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.020279163642627846
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.000541419	0.020279163642627846
LASSA FEVER	0.000541419	0.020279163642627846
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.020279163642627846
ONDINE SYNDROME	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.020279163642627846
HEREDITARY COPROPORPHYRIA	0.000541419	0.020279163642627846
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.020279163642627846
EPISODIC ATAXIA TYPE 3	0.000541419	0.020279163642627846
LHERMITTE-DUCLOS DISEASE	0.000541419	0.020279163642627846
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020279163642627846
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020279163642627846
HADDAD SYNDROME	0.000541419	0.020279163642627846
SCLERODERMA	0.000541419	0.020279163642627846
9Q33.3Q34.11 MICRODELETION SYNDROME	0.000541419	0.020279163642627846
DERMOTRICHIC SYNDROME	0.000541419	0.020279163642627846
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020279163642627846
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020279163642627846
PARTINGTON SYNDROME	0.000541419	0.020279163642627846
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.020279163642627846
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020279163642627846
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020279163642627846
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020279163642627846
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020279163642627846
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.000541419	0.020279163642627846
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020279163642627846
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.020279163642627846
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.020279163642627846
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020279163642627846
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020279163642627846
CENTRONUCLEAR MYOPATHY	0.000541419	0.020279163642627846
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020279163642627846
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.020279163642627846
MOGS-CDG	0.000541419	0.020279163642627846
MALAN OVERGROWTH SYNDROME	0.000541419	0.020279163642627846
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020279163642627846
ANGELMAN SYNDROME	0.000541419	0.020279163642627846
HYPERPROLINEMIA TYPE 1	0.000541419	0.020279163642627846
ALG9-CDG	0.000541419	0.020279163642627846
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020279163642627846
PORPHYRIA VARIEGATA	0.000541419	0.020279163642627846
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.020279163642627846
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.020279163642627846
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.020279163642627846
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020279163642627846
SAETHRE-CHOTZEN SYNDROME	0.000541419	0.020279163642627846
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.020279163642627846
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.020279163642627846
ENCEPHALITIS LETHARGICA	0.000541419	0.020279163642627846
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.020279163642627846
CAMOS SYNDROME	0.000541419	0.020279163642627846
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.020279163642627846
FAMILIAL THROMBOCYTOSIS	0.000541419	0.020279163642627846
ADDISON DISEASE	0.000541419	0.020279163642627846
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.000541419	0.020279163642627846
FETAL GAUCHER DISEASE	0.000541419	0.020279163642627846
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.020279163642627846
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020279163642627846
HYPOPHOSPHATASIA	0.000541419	0.020279163642627846
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.020279163642627846
MYASTHENIA GRAVIS	0.000541419	0.020279163642627846
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020279163642627846
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020279163642627846
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.000541419	0.020279163642627846
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.000541419	0.020279163642627846
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020279163642627846
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020279163642627846
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020279163642627846
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020279163642627846
WHIM SYNDROME	0.000541419	0.020279163642627846
GRANULOMATOSIS WITH POLYANGIITIS	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020279163642627846
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.020279163642627846
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020279163642627846
PROTEUS SYNDROME	0.000541419	0.020279163642627846
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020279163642627846
ASPARTYLGLUCOSAMINURIA	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.020279163642627846
LEIGH SYNDROME	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.020279163642627846
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.020279163642627846
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020279163642627846
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020279163642627846
MILLER-DIEKER SYNDROME	0.000541419	0.020279163642627846
LIPOID PROTEINOSIS	0.000541419	0.020279163642627846
ALG2-CDG	0.000541419	0.020279163642627846
PORPHYRIA	0.000541419	0.020279163642627846
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.020279163642627846
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.020279163642627846
SYSTEMIC SCLEROSIS	0.000541419	0.020279163642627846
INSULINOMA	0.000541419	0.020279163642627846
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.020279163642627846
SCRUB TYPHUS	0.000541419	0.020279163642627846
MPDU1-CDG	0.000541419	0.020279163642627846
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020279163642627846
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020279163642627846
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020279163642627846
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020279163642627846
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020279163642627846
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020279163642627846
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020279163642627846
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020279163642627846
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.020279163642627846
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.020279163642627846
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000541419	0.020279163642627846
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.020279163642627846
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.020279163642627846
OROFACIODIGITAL SYNDROME I; OFD1	0.000541419	0.020279163642627846
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.020279163642627846
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020279163642627846
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.000541419	0.020279163642627846
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.020279163642627846
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020279163642627846
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.020279163642627846
RENPENNING SYNDROME 1; RENS1	0.000541419	0.020279163642627846
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020279163642627846
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020279163642627846
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.020279163642627846
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020279163642627846
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.020279163642627846
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020279163642627846
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020279163642627846
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.020279163642627846
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020279163642627846
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020279163642627846
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.020279163642627846
PALLISTER-KILLIAN SYNDROME	0.000541419	0.020279163642627846
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.020279163642627846
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020279163642627846
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.000541419	0.020279163642627846
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.020279163642627846
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020279163642627846
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020279163642627846
GURRIERI SYNDROME	0.000541419	0.020279163642627846
MENKES DISEASE	0.000541419	0.020279163642627846
LOWE OCULOCEREBRORENAL SYNDROME	0.000541419	0.020279163642627846
INCONTINENTIA PIGMENTI; IP	0.000541419	0.020279163642627846
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.020279163642627846
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020279163642627846
ATKIN-FLAITZ SYNDROME	0.000541419	0.020279163642627846
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020279163642627846
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000541419	0.020279163642627846
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.020279163642627846
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020279163642627846
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020279163642627846
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020279163642627846
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020279163642627846
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.020279163642627846
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020279163642627846
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.020279163642627846
IMMUNODEFICIENCY 47	0.000541419	0.020279163642627846
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020279163642627846
HHHH SYNDROME	0.000541419	0.020279163642627846
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.020279163642627846
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.020279163642627846
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.020279163642627846
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.020279163642627846
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020279163642627846
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020279163642627846
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020279163642627846
CLARK-BARAITSER SYNDROME	0.000541419	0.020279163642627846
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020279163642627846
CRANIOSYNOSTOSIS 2	0.000541419	0.020279163642627846
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.020279163642627846
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020279163642627846
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020279163642627846
NOONAN SYNDROME 7; NS7	0.000541419	0.020279163642627846
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000541419	0.020279163642627846
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020279163642627846
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.020279163642627846
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.020279163642627846
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020279163642627846
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020279163642627846
EPISODIC ATAXIA, TYPE 6	0.000541419	0.020279163642627846
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.020279163642627846
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.020279163642627846
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.020279163642627846
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.020279163642627846
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020279163642627846
PERRAULT SYNDROME 3	0.000541419	0.020279163642627846
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.020279163642627846
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.020279163642627846
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.020279163642627846
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.020279163642627846
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.020279163642627846
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.020279163642627846
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020279163642627846
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.020279163642627846
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020279163642627846
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020279163642627846
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.000541419	0.020279163642627846
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.020279163642627846
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020279163642627846
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020279163642627846
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020279163642627846
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000541419	0.020279163642627846
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000541419	0.020279163642627846
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020279163642627846
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020279163642627846
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.020279163642627846
ALZHEIMER DISEASE 3; AD	0.000541419	0.020279163642627846
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020279163642627846
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.020279163642627846
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020279163642627846
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000541419	0.020279163642627846
LATHOSTEROLOSIS	0.000541419	0.020279163642627846
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020279163642627846
KUFOR-RAKEB SYNDROME	0.000541419	0.020279163642627846
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020279163642627846
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020279163642627846
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.020279163642627846
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020279163642627846
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.020279163642627846
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.020279163642627846
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.000541419	0.020279163642627846
LISSENCEPHALY 3; LIS3	0.000541419	0.020279163642627846
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.020279163642627846
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020279163642627846
PITT-HOPKINS SYNDROME	0.000541419	0.020279163642627846
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020279163642627846
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020279163642627846
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.020279163642627846
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020279163642627846
KLEEFSTRA SYNDROME	0.000541419	0.020279163642627846
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.020279163642627846
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020279163642627846
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020279163642627846
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020279163642627846
XYLOSIDASE DEFICIENCY	0.000541419	0.020279163642627846
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020279163642627846
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020279163642627846
COCKAYNE SYNDROME A; CSA	0.000541419	0.020279163642627846
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.020279163642627846
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020279163642627846
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020279163642627846
ACROCALLOSAL SYNDROME; ACLS	0.000541419	0.020279163642627846
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000541419	0.020279163642627846
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.020279163642627846
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.020279163642627846
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.020279163642627846
STURGE-WEBER SYNDROME	0.000541419	0.020279163642627846
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020279163642627846
SNEDDON SYNDROME	0.000541419	0.020279163642627846
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.000541419	0.020279163642627846
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.020279163642627846
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020279163642627846
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020279163642627846
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020279163642627846
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020279163642627846
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020279163642627846
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020279163642627846
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.020279163642627846
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.000541419	0.020279163642627846
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000541419	0.020279163642627846
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.020279163642627846
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020279163642627846
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.020279163642627846
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.020279163642627846
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000541419	0.020279163642627846
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000541419	0.020279163642627846
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020279163642627846
BANGSTAD SYNDROME	0.000541419	0.020279163642627846
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000541419	0.020279163642627846
SECKEL SYNDROME 1; SCKL1	0.000541419	0.020279163642627846
AUTISM	0.000541419	0.020279163642627846
PARIETAL FORAMINA	0.000541419	0.020279163642627846
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020279163642627846
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020279163642627846
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.020279163642627846
CROUZON SYNDROME	0.000541419	0.020279163642627846
CORNELIA DE LANGE SYNDROME 1	0.000541419	0.020279163642627846
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.020279163642627846
PAPILLORENAL SYNDROME	0.000541419	0.020279163642627846
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020279163642627846
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.020279163642627846
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.020279163642627846
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.020279163642627846
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020279163642627846
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.020279163642627846
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.020279163642627846
2Q33.1 DELETION SYNDROME	0.000541419	0.020279163642627846
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.020279163642627846
1P36 MICRODELETION SYNDROME	0.000541419	0.020279163642627846
DARIER-WHITE DISEASE; DAR	0.000541419	0.020279163642627846
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.020279163642627846
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020279163642627846
HUNTINGTON DISEASE; HD	0.000541419	0.020279163642627846
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.020279163642627846
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020279163642627846
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020279163642627846
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020279163642627846
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020279163642627846
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020279163642627846
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.020279163642627846
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.020279163642627846
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.020279163642627846
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020279163642627846
FLYNN-AIRD SYNDROME	0.000541419	0.020279163642627846
ZIMMERMANN-LABAND SYNDROME 1	0.000541419	0.020279163642627846
EPILEPSY, READING	0.000541419	0.020279163642627846
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020279163642627846
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.020279163642627846
COHEN SYNDROME	0.000541419	0.020279163642627846
THREONINEMIA	0.000541419	0.020279163642627846
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020279163642627846
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020279163642627846
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.020279163642627846
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.020279163642627846
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.020279163642627846
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.020279163642627846
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.020279163642627846
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020279163642627846
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020279163642627846
OHDO SYNDROME	0.000541419	0.020279163642627846
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020279163642627846
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.000541419	0.020279163642627846
MARDEN-WALKER SYNDROME	0.000541419	0.020279163642627846
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.020279163642627846
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.020279163642627846
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020279163642627846
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.020279163642627846
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.020279163642627846
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.020279163642627846
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.020279163642627846
TAY-SACHS DISEASE; TSD	0.000541419	0.020279163642627846
FILIPPI SYNDROME; FLPIS	0.000541419	0.020279163642627846
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.020279163642627846
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020279163642627846
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.020279163642627846
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.020279163642627846
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020279163642627846
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020279163642627846
RAMON SYNDROME	0.000541419	0.020279163642627846
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.020279163642627846
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020279163642627846
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020279163642627846
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.020279163642627846
NEURAMINIDASE DEFICIENCY	0.000541419	0.020279163642627846
KIFAFA SEIZURE DISORDER	0.000541419	0.020279163642627846
KEUTEL SYNDROME; KTLS	0.000541419	0.020279163642627846
KAPUR-TORIELLO SYNDROME	0.000541419	0.020279163642627846
EPILEPSY-TELANGIECTASIA	0.000541419	0.020279163642627846
GAPO SYNDROME; GAPOS	0.000541419	0.020279163642627846
FRYNS SYNDROME; FRNS	0.000541419	0.020279163642627846
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020279163642627846
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020279163642627846
FOUNTAIN SYNDROME	0.000541419	0.020279163642627846
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.020279163642627846
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020279163642627846
BERNARD-SOULIER SYNDROME	0.000541419	0.020279163642627846
DIAMINOPENTANURIA	0.000541419	0.020279163642627846
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020279163642627846
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.020279163642627846
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.020279163642627846
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020279163642627846
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020279163642627846
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.020279163642627846
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.020279163642627846
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020279163642627846
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020279163642627846
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020279163642627846
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.020279163642627846
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.020279163642627846
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020279163642627846
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.020279163642627846
HYPERPROLINEMIA, TYPE II	0.000541419	0.020279163642627846
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.000541419	0.020279163642627846
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.000541419	0.020279163642627846
HYPERLYSINEMIA, TYPE I	0.000541419	0.020279163642627846
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.020279163642627846
HYPER-BETA-ALANINEMIA	0.000541419	0.020279163642627846
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020279163642627846
MOWAT-WILSON SYNDROME; MOWS	0.000541419	0.020279163642627846
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000541419	0.020279163642627846
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.020279163642627846
COWDEN SYNDROME 5; CWS5	0.000541419	0.020279163642627846
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020279163642627846
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020279163642627846
SUBEPENDYMOMA	0.000541419	0.020279163642627846
EPENDYMOMA	0.000541419	0.020279163642627846
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.020279163642627846
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.020279163642627846
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.020279163642627846
AICA-RIBOSIDURIA	0.000541419	0.020279163642627846
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020279163642627846
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.020279163642627846
CITRULLINEMIA TYPE I	0.000541419	0.020279163642627846
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020279163642627846
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020279163642627846
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.020279163642627846
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020279163642627846
SANJAD-SAKATI SYNDROME	0.000541419	0.020279163642627846
KABUKI SYNDROME	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.020279163642627846
PINEOBLASTOMA	0.000541419	0.020279163642627846
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.000541419	0.020279163642627846
16Q24.3 MICRODELETION SYNDROME	0.000541419	0.020279163642627846
THANATOPHORIC DYSPLASIA	0.000541419	0.020279163642627846
COG5-CDG	0.000541419	0.020279163642627846
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020279163642627846
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.020279163642627846
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.020279163642627846
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020279163642627846
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.020279163642627846
MICROSPORIDIOSIS	0.000541419	0.020279163642627846
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.020279163642627846
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020279163642627846
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020279163642627846
MOYNAHAN SYNDROME	0.000541419	0.020279163642627846
MOYAMOYA DISEASE	0.000541419	0.020279163642627846
MOMO SYNDROME	0.000541419	0.020279163642627846
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020279163642627846
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.020279163642627846
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.020279163642627846
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020279163642627846
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020279163642627846
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020279163642627846
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020279163642627846
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020279163642627846
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.020279163642627846
ACROCARDIOFACIAL SYNDROME	0.000541419	0.020279163642627846
EPISODIC ATAXIA TYPE 6	0.000541419	0.020279163642627846
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.000541419	0.020279163642627846
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.020279163642627846
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020279163642627846
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.020279163642627846
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.020279163642627846
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.020279163642627846
HARROD SYNDROME	0.000541419	0.020279163642627846
2Q23.1 MICRODELETION SYNDROME	0.000541419	0.020279163642627846
CONGENITAL HYDROCEPHALUS	0.000541419	0.020279163642627846
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.020279163642627846
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020279163642627846
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.000541419	0.020279163642627846
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020279163642627846
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.000541419	0.020279163642627846
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020279163642627846
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.020279163642627846
CYSTATHIONINURIA	0.000541419	0.020279163642627846
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020279163642627846
MOWAT-WILSON SYNDROME	0.000541419	0.020279163642627846
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020279163642627846
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020279163642627846
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020279163642627846
HENNEKAM SYNDROME	0.000541419	0.020279163642627846
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020279163642627846
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.020279163642627846
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.020279163642627846
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020279163642627846
VIRAL HEMORRHAGIC FEVER	0.000541419	0.020279163642627846
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.020279163642627846
THYROCEREBRORENAL SYNDROME	0.000541419	0.020279163642627846
TETRASOMY 18P	0.000541419	0.020279163642627846
DUPLICATION/INVERSION 15Q11	0.000541419	0.020279163642627846
TAKAYASU ARTERITIS	0.000541419	0.020279163642627846
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020279163642627846
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.020279163642627846
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.020279163642627846
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020279163642627846
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.020279163642627846
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.020279163642627846
RENPENNING SYNDROME	0.000541419	0.020279163642627846
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020279163642627846
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.020279163642627846
WORSTER-DROUGHT SYNDROME	0.000541419	0.020279163642627846
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.020279163642627846
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020279163642627846
CLASSIC HOMOCYSTINURIA	0.000541419	0.020279163642627846
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.020279163642627846
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020279163642627846
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.020279163642627846
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.020279163642627846
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.020279163642627846
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020279163642627846
CHIME SYNDROME	0.000541419	0.020279163642627846
GLIOBLASTOMA	0.000541419	0.020279163642627846
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020279163642627846
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020279163642627846
GM1 GANGLIOSIDOSIS	0.000541419	0.020279163642627846
GALACTOSIALIDOSIS	0.000541419	0.020279163642627846
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020279163642627846
FOUNTAIN SYNDROME	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.020279163642627846
HEREDITARY HYPEREKPLEXIA	0.000541419	0.020279163642627846
TYROSINEMIA TYPE 2	0.000541419	0.020279163642627846
PROLACTINOMA	0.000541419	0.020279163642627846
PORENCEPHALY	0.000541419	0.020279163642627846
CRONKHITE-CANADA SYNDROME	0.000541419	0.020279163642627846
CONGENITAL RUBELLA SYNDROME	0.000541419	0.020279163642627846
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020279163642627846
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.020279163642627846
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.020279163642627846
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020279163642627846
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020279163642627846
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.020279163642627846
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020279163642627846
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020279163642627846
OROFACIODIGITAL SYNDROME TYPE 1	0.000541419	0.020279163642627846
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.020279163642627846
RAMON SYNDROME	0.000541419	0.020279163642627846
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.020279163642627846
20P13 MICRODELETION SYNDROME	0.000541419	0.020279163642627846
RIFT VALLEY FEVER	0.000541419	0.020279163642627846
EBOLA HEMORRHAGIC FEVER	0.000541419	0.020279163642627846
LUJO HEMORRHAGIC FEVER	0.000541419	0.020279163642627846
WIEDEMANN-STEINER SYNDROME	0.000541419	0.020279163642627846
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020279163642627846
15Q OVERGROWTH SYNDROME	0.000541419	0.020279163642627846
NOCARDIOSIS	0.000541419	0.020279163642627846
ISOLATED BILIARY ATRESIA	0.000541419	0.020279163642627846
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.020279163642627846
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.020279163642627846
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020279163642627846
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020279163642627846
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020279163642627846
FRONTAL ENCEPHALOCELE	0.000541419	0.020279163642627846
COWDEN SYNDROME 6; CWS6	0.000541419	0.020279163642627846
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.020279163642627846
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020279163642627846
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000541419	0.020279163642627846
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.000541419	0.020279163642627846
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.020279163642627846
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.020279163642627846
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.020279163642627846
PSEUDO-TORCH SYNDROME 2	0.000541419	0.020279163642627846
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.020279163642627846
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.020279163642627846
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020279163642627846
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.020279163642627846
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020279163642627846
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.020279163642627846
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020279163642627846
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020279163642627846
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020279163642627846
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.020279163642627846
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.020279163642627846
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.020279163642627846
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020279163642627846
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020279163642627846
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.020279163642627846
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000541419	0.020279163642627846
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020279163642627846
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.020279163642627846
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020279163642627846
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020279163642627846
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020279163642627846
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.020279163642627846
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.020279163642627846
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020279163642627846
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000541419	0.020279163642627846
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.020279163642627846
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020279163642627846
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020279163642627846
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020279163642627846
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000541419	0.020279163642627846
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020279163642627846
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020279163642627846
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020279163642627846
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.020279163642627846
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020279163642627846
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.020279163642627846
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.020279163642627846
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.020279163642627846
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020279163642627846
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.020279163642627846
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.000541419	0.020279163642627846
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000541419	0.020279163642627846
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.020279163642627846
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020279163642627846
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.020279163642627846
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020279163642627846
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.020279163642627846
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020279163642627846
TENORIO SYNDROME; TNORS	0.000541419	0.020279163642627846
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020279163642627846
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.020279163642627846
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.020279163642627846
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.020279163642627846
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.020279163642627846
ROSAÃ-DORFMAN DISEASE	0.000541419	0.020279163642627846
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020279163642627846
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.020279163642627846
KNOBLOCH SYNDROME	0.000541419	0.020279163642627846
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020279163642627846
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.020279163642627846
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.020279163642627846
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020279163642627846
CRYPTOCOCCOSIS	0.000541419	0.020279163642627846
CRISPONI SYNDROME	0.000541419	0.020279163642627846
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020279163642627846
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020279163642627846
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.020279163642627846
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020279163642627846
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.000541419	0.020279163642627846
DISTAL MONOSOMY 3P	0.000541419	0.020279163642627846
DISTAL MONOSOMY 7Q36	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.000541419	0.020279163642627846
DYSEQUILIBRIUM SYNDROME	0.000541419	0.020279163642627846
COCKAYNE SYNDROME	0.000541419	0.020279163642627846
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.020279163642627846
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.020279163642627846
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020279163642627846
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020279163642627846
CENTRAL DIABETES INSIPIDUS	0.000541419	0.020279163642627846
FAMILIAL DYSAUTONOMIA	0.000541419	0.020279163642627846
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020279163642627846
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020279163642627846
DISTAL TRISOMY 15Q	0.000541419	0.020279163642627846
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020279163642627846
WOLCOTT-RALLISON SYNDROME	0.000541419	0.020279163642627846
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020279163642627846
RING CHROMOSOME 10 SYNDROME	0.000541419	0.020279163642627846
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020279163642627846
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.020279163642627846
ROMANO-WARD SYNDROME	0.000541419	0.020279163642627846
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020279163642627846
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020279163642627846
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020279163642627846
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.020279163642627846
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.020279163642627846
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020279163642627846
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020279163642627846
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020279163642627846
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020279163642627846
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020279163642627846
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020279163642627846
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020279163642627846
ATAXIA-TELANGIECTASIA	0.000541419	0.020279163642627846
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000541419	0.020279163642627846
BETA-MANNOSIDOSIS	0.000541419	0.020279163642627846
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020279163642627846
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.020279163642627846
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.020279163642627846
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020279163642627846
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.000541419	0.020279163642627846
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.020279163642627846
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.020279163642627846
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.020279163642627846
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020279163642627846
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020279163642627846
C SYNDROME	0.000541419	0.020279163642627846
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.020279163642627846
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.020279163642627846
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.020279163642627846
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020279163642627846
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020279163642627846
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.020279163642627846
